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1. Introduction 
1.1.  Amyloidosis 
Proteins are macromolecules, composed of the 20 naturally occurring L-amino acids, 
which are involved in almost all biological processes. In order to function, proteins 
fold from a random coil state to their three-dimensional native conformation. 
Considering the prominent role of proteins and the complexity of their folding 
process, it is not surprising that protein misfolding might result in diseases (1). 
Several human protein misfolding diseases have been reported, of which the 
amyloidoses represent the largest group, including Alzheimer’s disease, Parkinson’s 
disease, Huntington’s disease and type II diabetes (2). Amyloidoses are characterized 
by the deposits of amyloid fibrils, which are composed of a single peptide or protein. 
In general, these deposits are extracellular, although also intracellular deposits of 
amyloid fibrils have been observed (3). Although the precursor peptides/proteins of 
amyloid firbrils differ substantially with respect to size, sequence and structure, the 
corresponding amyloid fibrils show high similarity in both external morphology and 
internal structure (4). Amyloid fibrils are long, unbranched filaments with diameters 
of 60-120Å and composed of 2-6 subunits, named protofilaments, which are often 
twisted around one another (5, 6). In these protofilaments, the peptides/proteins 
exhibit the characteristic cross-β structure, in which the individual β-strands run 
perpendicular to the fibril axis (7). Interestingly, it has been observed that also non-
amyloidogenic proteins can form amyloid fibrils under specific conditions (8). These 
observations support the idea that the formation of amyloid fibrils is a basic property 
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of the polypeptide chains. Although amyloid fibrils are strongly linked to diseases, 
there are also examples of nonpathological, functional amyloid fibrils (2) 
 
1.2. Alzheimer’s disease (AD) 
In 1906, the German psychiatrist Alois Alzheimer (1864-1915) gave a talk at the 37th 
Conference of South-West German Psychiatrists in Tübingen, reporting on a new 
form of dementia. In his talk, he described the psychiatric symptoms and the changes 
in brain histology of an earlier patient Auguste Deter, who died at the age of 56 (9). 
Although Alzheimer’s talk attracted very little attention from the audience, Emile 
Kraepelin, a famous German professor of psychiatry and Alzheimer’s superior, 
introduced only four years later this newly discovered form of dementia in his 
textbook of psychiatry for students and practitioners and named it Alzheimer’s 
disease (AD) (10).  
Today, AD is the major form of dementia, responsible for nearly 60 to 80% of all 
dementia case (11). In 2005, the worldwide prevalence of dementia was estimated to 
be 24.3 million, with the highest predicted increase rates in China, India and Latin 
America (12). Two forms of AD are distinguished: the familial form (FAD), which 
accounts only for less than 5% of all cases, and the more prevalent sporadic form 
(13). FAD is caused by mutations in genes of amyloid precursor protein (APP) (14), 
presenilin 1 (15) and presenilin 2 (16) , and is characterized by the early onset of the 
disease (<60 years), whereas the sporadic form of AD (henceforth called AD) is 
rarely observed under the age of 65 years (17). Several risk factors have been 
reported for AD, including age (18), genetic factors (19), including apolipoprotein E 
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(20), type 2 diabetes mellitus (21, 22), depression (23, 24), body weight (25, 26), 
midlife hypertension (27, 28) and smoking (29, 30).  
However, the major risk factor of the disease is age, as indicated by the increase of 
the age-specific incidence rate of AD from 0.1% at the age 60-65 to 12.1% for 
individuals aged over 95 years (31). Due to the expected increase in life expectancy, 
the impact of the disease will even increase in the future. For the year 2050, a 
worldwide prevalence of 106.2 million is predicted, meaning that 1 in 85 persons 
living with AD (32). Therefore, AD represents a major future challenge for the 
society, including the enormous financial burden of the disease. In 2008, the total cost 
of dementia in the European Union has been estimated to be € 160 billion, of which 
56% were costs of informal care (33).  
The core clinical features of AD is the gradual and progressive decline in cognitive 
functions, including memory (particular the short-term memory), orientation, 
language and executive function, and noncognitive and behavioral symptoms, such as 
unawareness of deficits, apathy, psychosis and agitation (34). The patients lose their 
ability to cope with daily activities and become dependent on caregivers. Although 
symptoms and rate of the disease vary considerable among different individuals, the 
end stage is associated with the almost complete loss of all cognitive functions, and 
death occurs usually by complications of aspiration, infection and inanition (35). The 
two major pathological hallmarks of AD are intracellular neurofibrillary tangles 
(NFTs), composed of the hyperphosphorylated tau protein (36), and extracellular 
senile plaques, which are mainly formed by the amyloid-β peptide (Aβ) (37). Further 
neuropathological changes include the loss of neurons and white matter, congophilic 
(amyloid) angiophaty and oxidative damage (38).  
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Despite enormous research effort, the exact pathological processes responsible for 
AD are still not completely understood. Although currently under debate (39, 40), the 
amyloid-beta hypothesis is the most accepted hypothesis for AD. The hypothesis 
states that the formation, aggregation and deposition of Aβ is the primary 
pathological event in AD (41, 42). Alternative hypothesis are the presenilin (43, 44) 
and the dual pathway hypothesis (45). Unfortunatly, there is currently still no drug 
available, which would prevent, stop or reverse the disease. Drugs approved by the 
FDA for the treatment of AD are cholinesterase inhibitors and N-methyl D-aspartate 
(NMDA), which regulates acetylcholine and glutamate in the brain (46). However, 
the benefits of these drugs are considered as only modest and transient (47, 48). The 
lack of an effective medication for AD emphasizes the importance of the prevention. 
Several of the above described risk factors of AD are partly or fully modifiable, such 
as body weight, hypertension and smoking. Several other factors have been reported 
to have preventive effect, such as physical activity (49), mediterranean diet (50) and 
extracts from turmeric, grapes and green tea (51). However, a national institute of 
health conference statement of 2010 concluded that there is not sufficient scientific 
evidence for the existence of modifiable factors (i.e. dietary factors, social or 
economic factors, or environmental exposures), which are associated with a reduced 
risk for AD (52) 
AD is a slow, progressive disorder, which lacks a defined event which can be 
considered as the onset of the disease. The disease is divided into three stages with 
defined diagnosis guidelines: the preclinical statge (53), mild cognitive impairement 
(MCI) (54) and dementia (55). A growing body of evidence indicates that the 
pathological processes of AD begin years before the clinical symptoms emerge (56). 
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Therefore, the reliable diagnosis of the so-called preclinical stage of the disease is a 
prerequisite for the better understanding of AD and the development and testing of 
effective drugs.  
 
1.3. Amyloid-β peptide (Aβ) 
The 39 to 42 amino acids long amyloid-β peptide (Aβ) has an amphiphilic character 
with a hydrophilic N-terminus (residues 1-28) and a hydrophobic C-terminal domain 
(residues 29-40/42). As displayed in figure X, the hydrophilic part contains 6 acidic 
amino acids (D1, E3, D7, E11, E22 and D23) with pKa values of 4.3-4.5, 3 basic amino 
acids (R5, K16 and K18) with pKa values of 10.2 and 3 histidine residues (H6, H13 and 
H14) with a pKa value of 6.5 (57). Therefore, the isoelectric point is 5.6, and the 
peptide has a net charge of -3.05 at pH 7.4.  
 
Aβ is formed by proteolytical processing of its precursor protein, the amyloid 
precursor protein (APP). APP is a type 1 transmembrane glycoprotein with a single 
membrane-spanning domain. Alternative splicing of the APP gene located on 
chromosome 21 leads to several isoforms, of which APP-695 is the most abundant in 
neurons (58). Although APP is present in many human tissues, its physiological role 
is poorly understood. In vitro and knockout studies (APP-deficient mice) suggested 
that APP may play a role in cell-cell adhesion (59), neurite outgrowth (60) and copper 
homeostasis (61). However, the further study of the physiological functions of APP is 
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considered as one of the major topic in future AD research (62). APP processing 
involves three types of proteases, termed α-, β-, and γ-secretases. Two principal 
processing pathways for APP are described: the amyloidogenic pathway and the non-
amyloidogenic pathway. In the amyloidogenic pathway, the consecutive action of the 
β-, and γ-secretase leads to the formation of Aβ. β-secretase cleaves APP at the N-
terminus of Aβ, generating a large N-terminal ectodomain APPsβ and the membrane-
bound fragment C99. This cleavage process is considered as the initial and rate-
limiting process (63). BACE 1, a membrane-bound aspartyl protease, was identified 
as β-secretase (64-66), and knockout studies demonstrated that it is the sole β-
secretase (67, 68). This exclusivity makes the β-secretase to a promising target of 
drug development. As BACE 1 has an activity optimum at pH 4.5, this cleavage step 
occurs in the endosomes. The fragment C99 is intramembranously cleaved by the γ-
secretase generating Aβ and APP intracellular domain (AICD). γ-secretase is a multi-
subunit protease complex composed of minimal four membrane proteins: presenilin, 
nicastrin (Nct), APH-1 and PEN-2 (69). As the site of γ-cleavage is not precise, 
several isoforms of Aβ are generated, of which Aβ(1-40) and Aβ(1-42) are the most 
abundant (70). The subcellular site of γ-cleavage is the plasma membrane and the 
endosomal/lysosomal system (70).  
Alternatively, in the non-amyloidogenic pathway the initial proteolysis step is 
processed by the α-secretase, which cleaves APP between Lys16 and Leu 17 in the 
Aβ domain (71). The α-cleavage occurs mainly at the cell surface, generating a large 
amino (N)-terminal ectodomain (sAPPα), which is released into the extracellular 
space, and a membrane-bound C-terminal fragment (C83). The fragment C83 is 
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further processed by γ-secretase, producing a truncated Aβ peptide named p3 and 
AICD (72), and therefore precluding the formation of Aβ.  
Aβ show polymorphic structures in solution, depending on the peptide concentration 
(73) and the environmental conditions, such as pH (74), salt (75), temperature (76) 
and solvent (77). In aqueous solution, monomeric Aβ exhibits a predominant random 
coil structure (73), whereas in organic solvent and membrane-mimicking systems Aβ 
favors an α-helical structure (78, 79). Aβ is prone to aggregate, forming oligomers, 
protofibrils and amyloid fibrils. In vitro, the aggregation process occurs in a 
nucleation-dependent reaction, similar to crystallization (80). A close link between 
the aggregation state and the neurotoxicity of Aβ has been established, although the 
exact molecular mechanisms of the Aβ toxicity are still unknown. In the beginning, 
the amyloid fibrils of Aβ were considered as the main source of Aβ toxicity (81, 82). 
However, recent studies indicated that non-fibrillar structure of Aβ, such as 
oligomers, amyloid-derived diffusible ligands (ADDLs) and protofibrils are more 
toxic (83-85). On the other hand, the monomeric Aβ has a very low toxic activity 
(86). 
Aβ has termed as “peptide from hell” not only because its putative toxic effect on 
neurons, but particular because the biophysical and biochemical handling is full of 
difficulties (87). A major problem is the low reproducibility in studies, investigating 
the kinetics of Aβ fibrillization and its neurotoxicity activity (88). Differences arise 
not only between Aβ purchased from different suppliers, but also between batches 
from the same manufacturer. In this respect, starting conformation and the 
aggregational state of the lyophilized peptide is seen as the major source of 
irreproducibility (87). Pre-existing aggregates can act as seeds in the Aβ fibrillization, 
1. Introduction 
 - 8 -  
and therefore affect both the kinetic of fibrillization process and the neurotoxic 
activity (80, 89). To remove any pre-existing aggregates, Aβ are usually treated with 
strong acids and organic solvents, such as hexafluoroisopropanol (HFIP), 
trifluoroacetic acid (TFA) and dimethylsulfoxide (DMSO). Furthermore, stock 
solutions of Aβ in aqueous buffer systems (higher than the corresponding critical 
concentration) should be avoided due to time-dependence of the Aβ aggregation 
process. Quantitative research with Aβ is moreover complicated by the lack of a 
tryptophan in the peptide sequence. UV absorbance is therefore precluded as a 
method to determine the peptide concentration. However, amino acid analysis is an 
accurate technique to determine the Aβ concentration.  
 
1.4. Biological membranes 
An important step in the origin of the first cellular life was the formation of a 
boundary structure, which separates the inside from the outside (90). In addition to 
their (selective) permeability barrier function, early membranes were assigned for 
further functions, including the capture of energy and its conversion into a suitable 
energy currency (91). These early membranes were composed of simple amphiphiles, 
such as fatty acids, fatty alcohols or monoglycerides (92). These molecules were 
formed under the prebiotic conditions on earth (93), and/or could be brought to earth 
via meteorites (94). However, it is still an unsolved mystery in the origins of cells, 
how the complex cytoplasm, containing ribosomes, nucleotides, RNA and even DNA 
got enclosed by the membrane. In the first scenario, the cellular system have evolved 
within the membrane boundary (95). Cellular precursor molecules would have 
crossed the early membrane, which, mainly composed of simple amphiphiles, have a 
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lower permeability compared to phospholipid bilayers (96). Alternatively, the second 
scenario suggests that the cytoplasm evolved to a large extent outside from a 
membrane shell, before it was engulfed by a lipid layer (97).  
Membranes of contemporary cells are involved in even more cellular processes, 
which is reflected in an more complex composition. These membranes are mainly 
composed of lipids and proteins, with a minor fraction of carbohydrates, which are 
covalently attached to either lipids (glycolipids) or proteins (glycoproteins) (98). In 
membrane, lipids are arranged in a bilayer structure, in which the hydrophobic 
domains constitute the hydrophobic core, whereas their hydrophilic domains interact 
with water (99). Mammalian membrane lipids can be divided into phospholipids, 
sphingolipids and the sterols (100). While cholesterol is almost the sole sterol in 
mammalian membranes, there exists a large diversity of phospho-and sphingolipids, 
by variations of the headgroup, chain length and extent of cis-unsaturations. As the 
lipid composition is tightly regulated in the different parts of the human body, it is not 
surprising that several diseases are associated with an aberrant lipid metabolism 
(101).  
 
 
 
 
 
 
1. Introduction 
 - 10 -  
1.5. Literature 
1. Dobson, C. M. (2004) Principles of protein folding, misfolding and 
aggregation, Semin Cell Dev Biol 15, 3-16. 
2. Chiti, F., and Dobson, C. M. (2006) Protein misfolding, functional amyloid, 
and human disease, Annu Rev Biochem 75, 333-366. 
3. Serpell, L. C., Berriman, J., Jakes, R., Goedert, M., and Crowther, R. A. 
(2000) Fiber diffraction of synthetic alpha-synuclein filaments shows 
amyloid-like cross-beta conformation, Proc Natl Acad Sci U S A 97, 4897-
4902. 
4. Stefani, M., and Dobson, C. M. (2003) Protein aggregation and aggregate 
toxicity: new insights into protein folding, misfolding diseases and biological 
evolution, J Mol Med (Berl) 81, 678-699. 
5. Shirahama, T., and Cohen, A. S. (1967) High-resolution electron microscopic 
analysis of the amyloid fibril, J Cell Biol 33, 679-708. 
6. Serpell, L. C., Sunde, M., Benson, M. D., Tennent, G. A., Pepys, M. B., and 
Fraser, P. E. (2000) The protofilament substructure of amyloid fibrils, J Mol 
Biol 300, 1033-1039. 
7. Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., and Blake, 
C. C. (1997) Common core structure of amyloid fibrils by synchrotron X-ray 
diffraction, J Mol Biol 273, 729-739. 
8. Fandrich, M., Fletcher, M. A., and Dobson, C. M. (2001) Amyloid fibrils 
from muscle myoglobin, Nature 410, 165-166. 
9. Alzheimer, A. (1906) Über einen eigenartigen schweren Erkrankungsprozeß 
der Hirnrinde, Neurologisches Centralblatt 23, 1129-1136. 
10. Kraepelin, E. (1910) Psychiatrie: Ein Lehrbuch für Studierende und Ärzte., 
Leipzig: Barth. 
11. Barnes, D. E., and Yaffe, K. (2011) The projected effect of risk factor 
reduction on Alzheimer's disease prevalence, Lancet Neurol 10, 819-828. 
12. Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., 
Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., 
Menezes, P. R., Rimmer, E., and Scazufca, M. (2005) Global prevalence of 
dementia: a Delphi consensus study, Lancet 366, 2112-2117. 
13. Hutton, M., and Hardy, J. (1997) The presenilins and Alzheimer's disease, 
Hum Mol Genet 6, 1639-1646. 
14. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., 
Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., and et al. (1991) 
Segregation of a missense mutation in the amyloid precursor protein gene 
with familial Alzheimer's disease, Nature 349, 704-706. 
15. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., 
Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. 
F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., 
Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasco, 
W., Da Silva, H. A., Haines, J. L., Perkicak-Vance, M. A., Tanzi, R. E., 
Roses, A. D., Fraser, P. E., Rommens, J. M., and St George-Hyslop, P. H. 
(1995) Cloning of a gene bearing missense mutations in early-onset familial 
Alzheimer's disease, Nature 375, 754-760. 
1. Introduction  
- 11 - 
16. Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., 
Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., and et al. (1995) Familial 
Alzheimer's disease in kindreds with missense mutations in a gene on 
chromosome 1 related to the Alzheimer's disease type 3 gene, Nature 376, 
775-778. 
17. Reitz, C., Brayne, C., and Mayeux, R. (2011) Epidemiology of Alzheimer 
disease, Nat Rev Neurol 7, 137-152. 
18. Katzman, R., and Saitoh, T. (1991) Advances in Alzheimer's disease, Faseb J 
5, 278-286. 
19. Daw, E. W., Payami, H., Nemens, E. J., Nochlin, D., Bird, T. D., 
Schellenberg, G. D., and Wijsman, E. M. (2000) The number of trait loci in 
late-onset Alzheimer disease, Am J Hum Genet 66, 196-204. 
20. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, 
P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. 
(1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's 
disease in late onset families, Science 261, 921-923. 
21. Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A., Hofman, A., and Breteler, 
M. M. (1999) Diabetes mellitus and the risk of dementia: The Rotterdam 
Study, Neurology 53, 1937-1942. 
22. Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., and Scheltens, P. 
(2006) Risk of dementia in diabetes mellitus: a systematic review, Lancet 
Neurol 5, 64-74. 
23. Jorm, A. F. (2001) History of depression as a risk factor for dementia: an 
updated review, Aust N Z J Psychiatry 35, 776-781. 
24. Ownby, R. L., Crocco, E., Acevedo, A., John, V., and Loewenstein, D. (2006) 
Depression and risk for Alzheimer disease: systematic review, meta-analysis, 
and metaregression analysis, Arch Gen Psychiatry 63, 530-538. 
25. Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., and Skoog, I. (2003) 
An 18-year follow-up of overweight and risk of Alzheimer disease, Arch 
Intern Med 163, 1524-1528. 
26. Razay, G., and Vreugdenhil, A. (2005) Obesity in middle age and future risk 
of dementia: midlife obesity increases risk of future dementia, Bmj 331, 455; 
author reply 455. 
27. Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., 
and Havlik, R. J. (2000) Midlife blood pressure and dementia: the Honolulu-
Asia aging study, Neurobiol Aging 21, 49-55. 
28. Qiu, C., Winblad, B., and Fratiglioni, L. (2005) The age-dependent relation of 
blood pressure to cognitive function and dementia, Lancet Neurol 4, 487-499. 
29. Ott, A., Slooter, A. J., Hofman, A., van Harskamp, F., Witteman, J. C., Van 
Broeckhoven, C., van Duijn, C. M., and Breteler, M. M. (1998) Smoking and 
risk of dementia and Alzheimer's disease in a population-based cohort study: 
the Rotterdam Study, Lancet 351, 1840-1843. 
30. Merchant, C., Tang, M. X., Albert, S., Manly, J., Stern, Y., and Mayeux, R. 
(1999) The influence of smoking on the risk of Alzheimer's disease, 
Neurology 52, 1408-1412. 
31. Brookmeyer, R., Gray, S., and Kawas, C. (1998) Projections of Alzheimer's 
disease in the United States and the public health impact of delaying disease 
onset, Am J Public Health 88, 1337-1342. 
1. Introduction 
 - 12 -  
32. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. (2007) 
Forecasting the global burden of Alzheimer's disease, Alzheimers Dement 3, 
186-191. 
33. Wimo, A., Jonsson, L., Gustavsson, A., McDaid, D., Ersek, K., Georges, J., 
Gulacsi, L., Karpati, K., Kenigsberg, P., and Valtonen, H. (2011) The 
economic impact of dementia in Europe in 2008-cost estimates from the 
Eurocode project, Int J Geriatr Psychiatry 26, 825-832. 
34. David S. Geldmacher, M. D. (2009) Alzheimer Disease, In The American 
Psychiatric Publishing Textbook of Alzheimer Disease and Other Dementias 
(Myron F. Weiner, M. D., and Anne M. Lipton, M.D., Ph.D., Ed.), American 
Psychiatric Publishing, Inc., Arlington, VA, USA. 
35. Tarawneh, R., and Holtzman, D. M. (2012) The clinical problem of 
symptomatic Alzheimer disease and mild cognitive impairment, Cold Spring 
Harb Perspect Med 2, a006148. 
36. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., and 
Wisniewski, H. M. (1986) Microtubule-associated protein tau. A component 
of Alzheimer paired helical filaments, J Biol Chem 261, 6084-6089. 
37. Glenner, G. G., and Wong, C. W. (1984) Alzheimer's disease and Down's 
syndrome: sharing of a unique cerebrovascular amyloid fibril protein, 
Biochem Biophys Res Commun 122, 1131-1135. 
38. Querfurth, H. W., and LaFerla, F. M. (2010) Alzheimer's disease, N Engl J 
Med 362, 329-344. 
39. Golde, T. E., Schneider, L. S., and Koo, E. H. (2011) Anti-abeta therapeutics 
in Alzheimer's disease: the need for a paradigm shift, Neuron 69, 203-213. 
40. Holtzman, D. M., Morris, J. C., and Goate, A. M. (2011) Alzheimer's disease: 
the challenge of the second century, Sci Transl Med 3, 77sr71. 
41. Hardy, J. A., and Higgins, G. A. (1992) Alzheimer's disease: the amyloid 
cascade hypothesis, Science 256, 184-185. 
42. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's 
disease: progress and problems on the road to therapeutics, Science 297, 353-
356. 
43. Sambamurti, K., Suram, A., Venugopal, C., Prakasam, A., Zhou, Y., Lahiri, 
D. K., and Greig, N. H. (2006) A partial failure of membrane protein turnover 
may cause Alzheimer's disease: a new hypothesis, Curr Alzheimer Res 3, 81-
90. 
44. Shen, J., and Kelleher, R. J., 3rd. (2007) The presenilin hypothesis of 
Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism, 
Proc Natl Acad Sci U S A 104, 403-409. 
45. Small, S. A., and Duff, K. (2008) Linking Abeta and tau in late-onset 
Alzheimer's disease: a dual pathway hypothesis, Neuron 60, 534-542. 
46. Salloway, S., and Correia, S. (2009) Alzheimer disease: time to improve its 
diagnosis and treatment, Cleve Clin J Med 76, 49-58. 
47. Lleo, A., Greenberg, S. M., and Growdon, J. H. (2006) Current 
pharmacotherapy for Alzheimer's disease, Annu Rev Med 57, 513-533. 
48. van Marum, R. J. (2008) Current and future therapy in Alzheimer's disease, 
Fundam Clin Pharmacol 22, 265-274. 
49. Etgen, T., Sander, D., Huntgeburth, U., Poppert, H., Forstl, H., and Bickel, H. 
(2010) Physical activity and incident cognitive impairment in elderly persons: 
the INVADE study, Arch Intern Med 170, 186-193. 
1. Introduction  
- 13 - 
50. Scarmeas, N., Stern, Y., Tang, M. X., Mayeux, R., and Luchsinger, J. A. 
(2006) Mediterranean diet and risk for Alzheimer's disease, Ann Neurol 59, 
912-921. 
51. Kim, J., Lee, H. J., and Lee, K. W. (2010) Naturally occurring phytochemicals 
for the prevention of Alzheimer's disease, J Neurochem 112, 1415-1430. 
52. Daviglus, M. L., Bell, C. C., Berrettini, W., Bowen, P. E., Connolly, E. S., Jr., 
Cox, N. J., Dunbar-Jacob, J. M., Granieri, E. C., Hunt, G., McGarry, K., Patel, 
D., Potosky, A. L., Sanders-Bush, E., Silberberg, D., and Trevisan, M. (2010) 
National Institutes of Health State-of-the-Science Conference statement: 
preventing alzheimer disease and cognitive decline, Ann Intern Med 153, 176-
181. 
53. Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, 
A. M., Iwatsubo, T., Jack, C. R., Jr., Kaye, J., Montine, T. J., Park, D. C., 
Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., 
Thies, B., Morrison-Bogorad, M., Wagster, M. V., and Phelps, C. H. (2011) 
Toward defining the preclinical stages of Alzheimer's disease: 
recommendations from the National Institute on Aging-Alzheimer's 
Association workgroups on diagnostic guidelines for Alzheimer's disease, 
Alzheimers Dement 7, 280-292. 
54. Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, 
N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. 
J., Carrillo, M. C., Thies, B., and Phelps, C. H. (2011) The diagnosis of mild 
cognitive impairment due to Alzheimer's disease: recommendations from the 
National Institute on Aging-Alzheimer's Association workgroups on 
diagnostic guidelines for Alzheimer's disease, Alzheimers Dement 7, 270-279. 
55. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., 
Jr., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., 
Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., 
Thies, B., Weintraub, S., and Phelps, C. H. (2011) The diagnosis of dementia 
due to Alzheimer's disease: recommendations from the National Institute on 
Aging-Alzheimer's Association workgroups on diagnostic guidelines for 
Alzheimer's disease, Alzheimers Dement 7, 263-269. 
56. Morris, J. C. (2005) Early-stage and preclinical Alzheimer disease, Alzheimer 
Dis Assoc Disord 19, 163-165. 
57. Ma, K., Clancy, E. L., Zhang, Y., Ray, D. G., Wollenberg, D., and Zagorski, 
M. G. (1999) Residue-Specific pKa Measurements of the β-Peptide and 
Mechanism of pH-Induced Amyloid Formation, J. Am. Chem. Soc. 121, 8698 
- 8706. 
58. Ponte, P., Gonzalez-DeWhitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg, 
B., Davis, K., Wallace, W., Lieberburg, I., and Fuller, F. (1988) A new A4 
amyloid mRNA contains a domain homologous to serine proteinase 
inhibitors, Nature 331, 525-527. 
59. Mattson, M. P. (1997) Cellular actions of beta-amyloid precursor protein and 
its soluble and fibrillogenic derivatives, Physiol Rev 77, 1081-1132. 
60. Muller, U., Cristina, N., Li, Z. W., Wolfer, D. P., Lipp, H. P., Rulicke, T., 
Brandner, S., Aguzzi, A., and Weissmann, C. (1994) Behavioral and 
anatomical deficits in mice homozygous for a modified beta-amyloid 
precursor protein gene, Cell 79, 755-765. 
1. Introduction 
 - 14 -  
61. White, A. R., Reyes, R., Mercer, J. F., Camakaris, J., Zheng, H., Bush, A. I., 
Multhaup, G., Beyreuther, K., Masters, C. L., and Cappai, R. (1999) Copper 
levels are increased in the cerebral cortex and liver of APP and APLP2 
knockout mice, Brain Res 842, 439-444. 
62. Hardy, J. (2009) The amyloid hypothesis for Alzheimer's disease: a critical 
reappraisal, J Neurochem 110, 1129-1134. 
63. Vassar, R. (2004) BACE1: the beta-secretase enzyme in Alzheimer's disease, 
J Mol Neurosci 23, 105-114. 
64. Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, 
C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., Smith, T. S., 
Simmons, D. L., Walsh, F. S., Dingwall, C., and Christie, G. (1999) 
Identification of a novel aspartic protease (Asp 2) as beta-secretase, Mol Cell 
Neurosci 14, 419-427. 
65. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., 
Doan, M., Dovey, H. F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., 
Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., 
Schenk, D., Seubert, P., Suomensaari, S. M., Wang, S., Walker, D., Zhao, J., 
McConlogue, L., and John, V. (1999) Purification and cloning of amyloid 
precursor protein beta-secretase from human brain, Nature 402, 537-540. 
66. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, 
P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., 
Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., 
Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M. 
(1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by 
the transmembrane aspartic protease BACE, Science 286, 735-741. 
67. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., and 
Wong, P. C. (2001) BACE1 is the major beta-secretase for generation of 
Abeta peptides by neurons, Nat Neurosci 4, 233-234. 
68. Roberds, S. L., Anderson, J., Basi, G., Bienkowski, M. J., Branstetter, D. G., 
Chen, K. S., Freedman, S. B., Frigon, N. L., Games, D., Hu, K., Johnson-
Wood, K., Kappenman, K. E., Kawabe, T. T., Kola, I., Kuehn, R., Lee, M., 
Liu, W., Motter, R., Nichols, N. F., Power, M., Robertson, D. W., Schenk, D., 
Schoor, M., Shopp, G. M., Shuck, M. E., Sinha, S., Svensson, K. A., Tatsuno, 
G., Tintrup, H., Wijsman, J., Wright, S., and McConlogue, L. (2001) BACE 
knockout mice are healthy despite lacking the primary beta-secretase activity 
in brain: implications for Alzheimer's disease therapeutics, Hum Mol Genet 
10, 1317-1324. 
69. Edbauer, D., Winkler, E., Regula, J. T., Pesold, B., Steiner, H., and Haass, C. 
(2003) Reconstitution of gamma-secretase activity, Nat Cell Biol 5, 486-488. 
70. Dries, D. R., and Yu, G. (2008) Assembly, maturation, and trafficking of the 
gamma-secretase complex in Alzheimer's disease, Curr Alzheimer Res 5, 132-
146. 
71. Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., 
Oltersdorf, T., McClure, D., and Ward, P. J. (1990) Cleavage of amyloid beta 
peptide during constitutive processing of its precursor, Science 248, 1122-
1124. 
72. Haass, C., Hung, A. Y., Schlossmacher, M. G., Teplow, D. B., and Selkoe, D. 
J. (1993) beta-Amyloid peptide and a 3-kDa fragment are derived by distinct 
cellular mechanisms, J Biol Chem 268, 3021-3024. 
1. Introduction  
- 15 - 
73. Terzi, E., Holzemann, G., and Seelig, J. (1995) Self-association of beta-
amyloid peptide (1-40) in solution and binding to lipid membranes, J Mol Biol 
252, 633-642. 
74. Huang, T. H., Yang, D. S., Plaskos, N. P., Go, S., Yip, C. M., Fraser, P. E., 
and Chakrabartty, A. (2000) Structural studies of soluble oligomers of the 
Alzheimer beta-amyloid peptide, J Mol Biol 297, 73-87. 
75. Klement, K., Wieligmann, K., Meinhardt, J., Hortschansky, P., Richter, W., 
and Fandrich, M. (2007) Effect of different salt ions on the propensity of 
aggregation and on the structure of Alzheimer's abeta(1-40) amyloid fibrils, J 
Mol Biol 373, 1321-1333. 
76. Gursky, O., and Aleshkov, S. (2000) Temperature-dependent beta-sheet 
formation in beta-amyloid Abeta(1-40) peptide in water: uncoupling beta-
structure folding from aggregation, Biochim Biophys Acta 1476, 93-102. 
77. Serpell, L. C. (2000) Alzheimer's amyloid fibrils: structure and assembly, 
Biochim Biophys Acta 1502, 16-30. 
78. Barrow, C. J., and Zagorski, M. G. (1991) Solution structures of beta peptide 
and its constituent fragments: relation to amyloid deposition, Science 253, 
179-182. 
79. Coles, M., Bicknell, W., Watson, A. A., Fairlie, D. P., and Craik, D. J. (1998) 
Solution structure of amyloid beta-peptide(1-40) in a water-micelle 
environment. Is the membrane-spanning domain where we think it is?, 
Biochemistry 37, 11064-11077. 
80. Harper, J. D., and Lansbury, P. T., Jr. (1997) Models of amyloid seeding in 
Alzheimer's disease and scrapie: mechanistic truths and physiological 
consequences of the time-dependent solubility of amyloid proteins, Annu Rev 
Biochem 66, 385-407. 
81. Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1991) In 
vitro aging of beta-amyloid protein causes peptide aggregation and 
neurotoxicity, Brain Res 563, 311-314. 
82. Roher, A. E., Ball, M. J., Bhave, S. V., and Wakade, A. R. (1991) Beta-
amyloid from Alzheimer disease brains inhibits sprouting and survival of 
sympathetic neurons, Biochem Biophys Res Commun 174, 572-579. 
83. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, 
M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of 
amyloid beta protein potently inhibit hippocampal long-term potentiation in 
vivo, Nature 416, 535-539. 
84. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., 
Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, 
P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, 
nonfibrillar ligands derived from Abeta1-42 are potent central nervous system 
neurotoxins, Proc Natl Acad Sci U S A 95, 6448-6453. 
85. Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. 
M., Teplow, D. B., and Selkoe, D. J. (1999) Protofibrillar intermediates of 
amyloid beta-protein induce acute electrophysiological changes and 
progressive neurotoxicity in cortical neurons, J Neurosci 19, 8876-8884. 
86. Ono, K., Condron, M. M., and Teplow, D. B. (2009) Structure-neurotoxicity 
relationships of amyloid beta-protein oligomers, Proc Natl Acad Sci U S A 
106, 14745-14750. 
1. Introduction 
 - 16 -  
87. Zagorski, M. G., Yang, J., Shao, H., Ma, K., Zeng, H., and Hong, A. (1999) 
Methodological and chemical factors affecting amyloid beta peptide 
amyloidogenicity, Methods Enzymol 309, 189-204. 
88. Fezoui, Y., Hartley, D. M., Harper, J. D., Khurana, R., Walsh, D. M., 
Condron, M. M., Selkoe, D. J., Lansbury, P. T., Jr., Fink, A. L., and Teplow, 
D. B. (2000) An improved method of preparing the amyloid beta-protein for 
fibrillogenesis and neurotoxicity experiments, Amyloid 7, 166-178. 
89. Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., 
Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., and Holzman, T. F. (1994) 
Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of 
amyloid with different chain lengths, Biophys J 67, 1216-1228. 
90. Szostak, J. W., Bartel, D. P., and Luisi, P. L. (2001) Synthesizing life, Nature 
409, 387-390. 
91. Deamer, D. W., and Dworkin, J. P. (2005) Chemistry and physics of primitive 
membranes, Top Curr Chem 259, 1-27. 
92. Monnard, P. A., and Deamer, D. W. (2002) Membrane self-assembly 
processes: Steps toward the first cellular life, Anat Record 268, 196-207. 
93. Deamer, D. W., and Oro, J. (1980) Role of lipids in prebiotic structures, 
Biosystems 12, 167-175. 
94. Mautner, M., Leonard, R. L., and Deamer, D. W. (1985) Meteorite organics in 
planetary envrionments: hydrothermal release, surface activity and microbial 
utilization, Planet Space Sci 43, 139-147. 
95. Luisi, P. L., Ferri, F., and Stano, P. (2006) Approaches to semi-synthetic 
minimal cells: a review, Naturwissenschaften 93, 1-13. 
96. Griffiths, G. (2007) Cell evolution and the problem of membrane topology, 
Nat Rev Mol Cell Biol 8, 1018-1024. 
97. Blobel, G. (1980) Intracellular protein topogenesis, Proc Natl Acad Sci U S A 
77, 1496-1500. 
98. Seelig, A., and Seelig, J. (2002) Membrane Structure, In Encyclopedia of 
Physical Science and Technology (Meyers, R. A., Ed.) 3rd ed., pp 355-367, 
N.Y.: Academic Press. 
99. Wilkins, M. H., Blaurock, A. E., and Engelman, D. M. (1971) Bilayer 
structure in membranes, Nat New Biol 230, 72-76. 
100. Simons, K., and Sampaio, J. L. (2011) Membrane organization and lipid rafts, 
Cold Spring Harb Perspect Biol 3, a004697. 
101. Wenk, M. R. (2005) The emerging field of lipidomics, Nat Rev Drug Discov 
4, 594-610. 
 
 
 
Chapter 2 
- 17 - 
2. Thermodynamics of the random-coil-to-β-sheet 
transition of Aβ(1-40) in a membrane environment 
Summary 
Alzheimer’s disease (AD) is the most common form of dementia with a worldwide 
prevalence of 20 to 30 million. The amyloid-β peptide (Aβ) is the main component of 
the amyloid plaques, which are considered as the major pathological hallmark of the 
disease. Aβ(1-40) reveals a random-coil-to-β-structure transition in the presence of 
anionic small unilamellar vesicles (SUVs). An additional structural transition of 
Aβ(1-40) to an α-helical structure can be observed at high lipid-to-peptide molar 
ratios. Here, we present a method to quantitatively determine the thermodynamic 
parameters of the random-coil-to-β-structure transition in the membrane environment. 
We have used Aβ(1-40) and four double-d isomers, in which two adjacent amino 
acids are replaced by their d-enantiomers. Double-d substitution has shown to result 
in a local disturbance of secondary structure without modifying other characteristics 
such as hydrophobicity and side-chain functionality. Circular dichroism (CD) 
spectroscopy provides the content of β-structure in solution and upon binding to 
anionic lipid membranes. By the use of anionic lipid vesicles containing 5mol% PEG-
PE, the transition to α-helix is inhibited and a conformational endpoint is observed. 
Thermodynamic parameters of membrane binding were determined with isothermal 
titration calorimetry. Linear regression analysis yields a linear correlation between the 
thermodynamic binding parameters and the extent of β-structure. β-structure 
formation of Aβ(1-40) at the membrane surface is thermodynamically characterized 
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by enthalpy change of  per residue, an entropy change of 
 residue and a free energy change of 
residue.  
Manuscript: Thermodynamics of the random-coil-to-β-sheet 
transition of Aβ(1-40) in a membrane environment 
Introduction 
Alzheimer’s disease (AD) is the major form of dementia, affecting estimated 25 
million people worldwide in 2005 (1). Predictions for the future indicate an dramatic 
increase of the worldwide prevalence of AD (106.2 million in 2050) (2). Despite 
enormous efforts, there is still no effective cure available for the disease. Besides the 
personal suffering of patients and their families, AD caused indirect and direct cost of 
$422 billion (3). Therefore, AD must be considered as a major future challenge for 
the society.  
Major pathological hallmarks of AD are extracellular neuritic plaques and 
intracellular neurofibrillary tangles. The core of neuritic plaques consists of amyloid 
fibrils, which are composed of the 39-43 amino acids long amyloid-β peptide (Aβ). In 
amyloid fibrils, Aβ exhibit a characteristic cross β-structure, in which the individual 
β-strands run perpendicular to the fibril axis (4). Aβ is formed by proteolytical 
cleavage of the amyloid precursor protein (APP), a type 1 transmembrane 
glycoprotein, by the consecutive action of β-, and γ-secretase (for review (5)). Aβ is 
in its solube, monomeric form a normal component of the cerebro spinal fluid (CSF) 
and the blood plasma (6-8). In vitro studies demonstrated that Aβ fibrilization is a 
nucleation-dependent process, comparable with crystallization (9, 10). Many factors 
1.01 /H kcal molβ∆ = −
3.62 /S cal molKβ∆ = − 0.04 /G kcal molβ∆ = −
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have been reported to influence the Aβ fibrillization, including pH (11, 12), salt (13), 
temperature (14) and seeds, such as preformed fibrils (15, 16) or glycosaminoglycans 
(17). However, the exact mechanism by which Aβ fibrillization occurs in vivo is still 
largely unknown. 
Originally, the Aβ fibrils were considered as the source of the putative neurotoxicity 
of Aβ (18, 19). More recent studies indicated that non-fibrillar structure of Aβ, 
including oligomers and protofibrils, are more neurotoxic (20). On the other hand, 
monomeric Aβ have a very low toxic activity (21). In aqueous solution, monomeric 
Aβ exhibits a predominant random-coil structure (22). However, Aβ exhibits β-
structure in in the fibrillar oligomers (23) and amyloid fibrils (4). Therefore, the 
structural conversion of Aβ from random-coil-to-β-structure is considered as crucial 
event in the pathology of the disease.  
Emerging evidences indicate that the lipid membrane plays a particular role in the 
course of AD. Several models for the membrane-mediated toxicity of Aβ were 
proposed, including the formation of ion-channel and pores in membranes, which 
leads to membrane depolarization and disruption of ionic homeostasis (24). 
Therefore, it is of particular interest to investigate the random-coil to β-structure 
transition in a membrane environment. Thermodynamic studies investigating the 
membrane-induced β-structure formation are relatively rare. Recent studies on the 
model peptide (KIGAKI)3 yielded in the thermodynamic characterization of the β-
structure formation in a membrane environment (25), which has been demonstrated to 
be dependent on the peptide chain length (26). 
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In this study, we aimed to characterize the thermodynamics of the membrane-induced 
β-structure formation of Aβ(1-40). For this purpose, we have used four double d-
isomers of Aβ(1-40) (d5, 6; d13, 14; d19, 20 and d35, 36 Aβ(1-40) ), in which two 
adjacent amino acids are substituted by the corresponding d-enantiomers. Double-d 
substitution has shown to result in a local disturbance of secondary structure without 
modifying other characteristics such as hydrophobicity and side-chain functionality 
(27, 28). Circular dichroism (CD) spectroscopy was used to quantify the content of β-
structure upon binding to anionic lipid membrane. Isothermal titration calorimetry 
(ITC) was applied to study the thermodynamic parameters of the binding process. 
The obtained thermodynamic parameters entail contributions of two different 
processes: (i) the adsorption of the peptide to the lipid membrane surface and (ii) 
conformational changes of the peptide from random-coil-to-β-structure. By 
correlating the thermodynamic binding parameters with the extent of membrane-
induced β-structure of the studied peptides, it was possible to separate these two 
different processes, deducing the thermodynamics of the β-structure formation of 
Aβ(1-40) in a membrane environment 
Material and Methods 
All lipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol (POPG), and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N[methoxy(polyethylene glycol)-2000] (mPEG 
2000 PE) were purchased from Avanti Polar Lipds (Alabaster, AL). Aβ(1-40) was 
obtained from rPeptide (Bogart, GA, USA). The double-d-isomers were kindly 
provided by Dr. M. Beyermann of the Leibniz-Institute für Molekulare 
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Pharmakologie, 13125 Berlin, Germany. All other chemical were purchased from 
commercial sources at the highest purity. 
Preparation of Lipid Vesicles 
Small unilamellar vesicles (SUVs) composed of ternary lipid mixture were prepared 
as follows. A defined amount of the first lipid was dried from a chloroform stock 
solution with a soft stream of nitrogen and then overnight in high vacuum. The 
amount of the first lipid was weighed and a defined amount of the second lipid was 
added. The mixture was treated as before  and the same procedure was applied for the 
third lipid. Typically, a buffer volume of 2-3 ml was added to the dried lipid film and 
the dispersion was extensively vortexed. Then, the lipid dispersion was sonicated 
with a G112SP1 Special Ultrasonic Cleaner (Laboratory Supplies CO., Inc) for 25 
min. Metal debris from the titanium tip was removed by centrifugation at 14,000 rpm 
for 4 min using an Eppendorf 5415 C benchtop centrifuge (Vaudaux-Eppendorf AG, 
Schonenbuch, Switzerland). The size and ζ-potential of the SUVs were measured by 
dynamic light scattering (DLS).  
Preparation of Aβ(1-40) solution  
Aβ(1-40) has been repeatedly reported to differ in fibrillogenic properties within 
different lots and suppliers, possibly caused by pre-existing aggregates. Therefore, it 
was crucial to establish a chemical starting point of the peptide. Treatment of Aβ(1-
40) with hexafluoroisopropanol (HFIP) dissolves pre-existing aggregates. Aβ(1-40) 
samples were prepared as follows. First, the peptides were dissolved in HFIP (at a 
concentration of 0.5 mg peptide/ ml HFIP) and equilibrated for one hour at room 
temperature. Then, an appropriate amount of the Aβ(1-40)-HFIP solution was 
aliquoted in 4ml glass tubes, and the solvent was removed by soft stream of nitrogen 
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and subsequent high vacuum overnight. The peptide samples were then stored at -20 
°C. Immediately prior to use, the peptide was dissolved in appropriate buffer (1min 
sonication). In general, a Aβ(1-40) concentration below 30 µM were used due to the 
confirmed structural stability within the time range of experiments. The peptide 
concentration was obtained by amino acid analysis (University of Bern).  
Circular Dichroism (CD) Spectroscopy 
All measurements were performed on a Chirascan CD spectrometer (Applied 
Photophysics Ltd., Leatherhead, UK). CD spectra were recorded from 190 nm to 250 
nm at 25 °C, with resolution of 1 nm, a bandwidth of 2 nm and a response time of 25 
s. A quartz cuvette with a path length of 1 mm was used for all measurements. The 
percentage of peptide secondary structure was estimated from a computer simulation 
based on the reference spectra obtained by Reed and Reed (29). 
Isothermal Titration Calorimetry (ITC) 
Isothermal Titration Calorimetry (ITC) measurements were performed on a VP ITC 
calorimeter (MicroCal, Northampton, MA). All measurements were made at 25 °C in 
5 mM Hepes (pH 7.0, 7.4 and 8.0). For the lipid-into-peptide titrations, the 
calorimeter cell contained the peptide solution at a concentration of below . 
Lipid vesicles were suspended in the same buffer as the peptide (~15mM lipid) and 
 aliquots were injected every  via a  syringe. As a control, every 
lipid vesicle suspension was injected into pure buffer. Raw data were processed using 
a Origin software provided with the instrument.  
25 Mµ
10 lµ 300 s 300 lµ
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Results 
Thermodynamics of peptide binding 
The thermodynamic characterization of a peptide-lipid binding reaction can be 
determined by high-sensitivity isothermal calorimetry (ITC). The general term 
“binding” is used in the following to describe the peptide adsorption from the bulk 
solution to the lipid membrane. Figure 1 show a representative example of an ITC 
experiment. The calorimetric cell contained a 25 µM Aβ(1-40) solution, which was 
titrated every 300 s with 10 µl aliquots of a 15 mM SUV suspension composed of 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoglycerol (POPG), and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N[methoxy(polyethylene glycol)-2000] (mPEG 2000 PE) 
(50/45/5 mol%) at 25 °C. Each injection caused an exothermic reaction as illustrated 
by the calorimetric trace. The heat of reaction corresponds to the integral of the 
titration peak and decreased with increasing number of injections as less peptide was 
available for binding (figure 1B). After about 27 injections all peptide was bound to 
the lipid membrane and further injections of lipid vesicles entailed only heats of 
dilution . As a control, lipid-into-buffer injections were conducted (data not 
shown). No significant heats were observed providing good evidence for a proper 
experimental set-up. The molar binding enthalpy, , can be calculated according 
to :  
  (1) 
jh
diluteh
0H∆
0 0
1
( ) /
n
j dilute pep
j
H h h n
=
∆ = −∑
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where is the total molar amount of peptide in the calorimetric cell and is the 
heat of dilution. The molar binding enthalpies for Aβ(1-40) and its double d-isomers 
are listed in table 1. They were dependent on the position of the double-d substitution 
and varied between for d13, 14 Aβ(1-40) and for d35, 
36 Aβ(1-40). Binding isotherm of the peptide-lipid interaction can be derived from 
the lipid-into-peptide calorimetric experiment as described elsewhere (30). Figure 2 
displays the binding isotherm for the ITC data of figure 1. The binding isotherm 
describes the dependence of the degree of binding, , on the equilibrium 
concentration of free peptide, . is defined as the molar ratio of bound peptide, 
, to lipid . Since Aβ(1-40) does not penetrate the lipid membrane, only the 
outer lipid layer is available for binding and  corresponds to 60% of the total lipid, 
 (31). The molar amount of bound peptide, , after i injections is linked to 
the calorimetric data according to  
  (2) 
where is the volume of the calorimetric cell and is the total peptide 
concentration in the cell. The molar amount of lipid available for binding is given by 
, where is the injection volume ( ) and is the concentration 
of the lipid suspension in the syringe. While the binding isotherm can be derived in a 
model-independent manner from the calorimetric data, the thermodynamic analysis of 
the binding isotherm requires the assumption of a specific binding model. The model 
used in the following is a surface partition model which states that peptide binding is 
0
pepn diluteh
17.5 /kcal mol− 1.1 /kcal mol−
bX
fc bX
,p boundn Ln
Ln
0
Ln ,pep bound
in
0
, 0,
1
/ ( )
i
i
pep bound j cell pep
j
n h H V c
=
= ∆ ⋅ ⋅∑
cellV 0, pepc
,0L inj Ln i V c= ⋅ ⋅ injV 10 lµ ,0Lc
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linearly correlated with the peptide concentration, , found immediately above the 
plane of binding (32): 
  (3) 
The binding constant  corresponds to the transfer of the peptide from the plane of 
binding into the membrane. The model takes into account that an anionic lipid 
membrane attract molecule bearing cationic groups such as Aβ(1-40). The peptide 
surface concentration  is therefore increased and an expression is given by the 
Boltzmann relation according to:  
  (4) 
where  is the effective peptide charge (charge which is exposed to the lipid 
membrane),  is the Faraday constant,  is the membrane surface potential and 
 the thermal energy. The application of the Gouy-Chapman theory allows the 
calculation of the surface potential  and the surface concentration  for each data 
point of the binding isotherm, leading to surface partition constant . The solid line 
in figure 2 is the best theoretical fit to the experimental data. For all peptides a good 
agreement between the model and the experimental data could be established. The 
binding constant  and the effective charge for all peptides are summarized in 
table 1. The free energy of binding, , is then given by 
  (5) 
Mc
0b MX K c= ⋅
0K
Mc
0 /pz F RT
M fc c e
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0F ψ
RT
ψ Mc
0K
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where the factor  is the molar concentration of water. Next, the entropy of 
binding, , is given by . The thermodynamic parameters of all 
peptides are summarized in table 1.  
Isothermal titration calorimetry was also used to study the pH dependence of Aβ(1-
40)-lipid interaction. Experiments were performed at three different pH values (7.0, 
7.4 and 8.0) in 5mM Hepes at 25 °C. Lipid-into-peptide titrations and theirs analysis 
were conducted as described above, and the binding parameters are summarized in 
table 2. At pH 8.0, no heats of reaction could be detected, and no binding constant 
, and therefore no , could be derived (n.d. in table 2). The molar binding enthalpy 
 increased with increasing pH values from  at 7.0 to 
 at 7.4 and reached  at 8.0. Further, the increases of pH 
form 7.0 to 7.4 lead to an small increase of the binding constant  from  to 
, whereas the effective charge  is decreased from  to . 
Structural transition of Aβ(1-40) peptides upon lipid binding 
Circular dichroism (CD) spectroscopy was performed to monitor structural changes 
of Aβ(1-40) and the double-d isomers upon binding to anionic lipid membrane. CD 
spectra of the peptides in buffer are shown in figure 3. All spectra revealed a 
predominantly random coil conformation. To obtain the fraction of secondary 
structure, the spectra are analyzed as described in the material and method section. 
Analysis revealed a nearly identical random coil content of 65.5 to 69.1% for all 
peptides. The contribution of β-structure varied from 21.7 to 33.4% and the content of 
α-helix was in the range of 0 to 11.4%. The detailed analysis is given in table 3. Upon 
addition of anionic lipid vesicles, the peptides were bound to the membrane surface 
55.5
0S∆ 0 0 0G H T S∆ = ∆ − ∆
0K
0G∆
0H∆ 18.9 /kcal mol−
13.5 /kcal mol− 0 /kcal mol
0K
10.04M −
10.06M − pz 1.1 0.2
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and experienced a conformational transition to β-structure as demonstrated in figure 
3B. As an example, figure 4 displays the CD spectra of Aβ(1-40) in presence of 
various concentration of lipid SUV composed of POPG/POPC/mPEG 2000 PE 
(45/50/5 mol%). The lipid-to-peptide ratio was gradually increased from 0 to 344. CD 
spectra recorded at high lipid-to-peptide ratio ensure complete peptide binding. An 
isosbestic point could be observed at  indicating a simple two-state 
equilibrium. The CD spectra were analyzed and the corresponding fractions of 
secondary structure are plotted versus the molar lipid-to-peptide ratio in figure 4B. 
The content of α-helix remained nearly constant and is not shown. The increase of the 
lipid-to-peptide ratios by 150 resulted in an increase of β-structure by 37%, while the 
random coil content decreased by the same magnitude. However, above a lipid-to-
peptide ratio of 150 the fractions of secondary structure elements remained constant 
which suggests a conformational endpoint. The existence of a conformational 
endpoint allows us to quantify the lipid-induced transition from random coil to β-
structure of Aβ(1-40). For this purpose, the change of β-structure, (%), is defined 
as , where  is the fraction of β-structure at the 
conformational endpoint and  in buffer. Next, the number of amino acids, 
, which transfer from random coil to β-structure, can be calculated according 
to , where  is the number of amino acids . The 
corresponding values for all peptides are summarized in table 3. The values of 
 varied from  to  , depending on the position of the double-d- 
substitution.  
213nmλ =
fβ∆
( ) ( )f f lipid f bufferβ β β∆ = − ( )f lipidβ
( )f bufferβ
( )aaβ∆
( ) aaaa f nββ∆ = ∆ ⋅ aan (40)
( )aaβ∆ 1.4 15.8
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Correlation of thermodynamics and structural changes of Aβ(1-40) peptides 
The binding of Aβ(1-40) and its double-d isomers to lipid membranes comprises two 
processes: (i) the adsorption to the membrane surface and (ii) conformational changes 
of the peptides. Similar adsorption energies can be assumed for all peptides as they 
possess nearly identical structure in solution. (~70% random coil, ~30% β-structure). 
Differences in the thermodynamic parameters are then caused by the conformational 
change upon binding to the membrane surface. A correlation between the 
thermodynamic parameters and  of the peptide binding reaction and 
the change in β-structure can be established as displayed in figure 5. Regression 
analysis yields a linear dependence of the thermodynamics on the change in β-
structure with the following expressions: 
  (6) 
  (7) 
  (8) 
where  is the number of amino acid residues that change from random coil to β-
structure. The contribution of the β-structure formation to the binding process 
corresponds to the slopes of the regression lines: 
 
 
 
0 0, ,G H∆ ∆ 0S∆
0 1.01 1.18( / )H n kcal molβ∆ = − ⋅∆ +
0 0.04 0.06( / )G n kcal molβ∆ = − ⋅∆ −
0 1.08 2.92( / )T S n kcal molβ∆ = − ⋅∆ +
nβ∆
1.01( 0.1) /H kcal mol per residueβ∆ = − ±
.002)0.04( 0 /G kcal mol per residueβ∆ = − ±
3.62( 0.5) /S cal molK per residueβ∆ = − ±
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From the intercept with the ordinate (0% β-structure) the thermodynamic binding 
parameters of a hypothetical Aβ(1-40) peptide with no conformational change can be 
estimated as: 
 
 
 
Discussion 
Structural aspect of membrane-peptide interactions 
Aβ(1-40) and four double-d isomers were used to derive information on the 
thermodynamics of the lipid-induced random coil-to-β-structure transition of Aβ(1-
40). For all peptides, CD spectroscopy provides evidence for a simple random coil-to-
β-structure transition induced by anionic PEGylated lipid vesicles. The incorporation 
of PEG into lipid vesicles avoids close contact between the vesicles and therefore 
prevents vesicle aggregation. Along with the prevention of vesicle aggregation, the 
addition of PEG-lipid in the lipid mixture inhibits the β-structure-α-helix transition 
observed at high lipid-to-peptide ratios in the case of nonPEGylated lipid vesicles 
(31). Therefore, it can be speculated that the β-structure-α-helix transition is due to 
dilution effect of a single Aβ(1-40) peptide induced by close contact of the lipid 
vesicles. Similar observations were made in the studies of the interaction of the cell-
penetrating peptide penetratin with lipid membranes (33). The interaction of 
penetratin with LUVs composed of either pure DOPG or DOPC/DOPG (60/40mol%) 
lead above a specific lipid-to-peptide ratio to vesicles aggregation followed by 
0 1.18 /H kcal mol∆ =
0 0.06 /G kcal mol∆ = −
0 9.8 /S cal mol K∆ =
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spontaneous disaggregation (34). Both processes are strongly linked to a 
conformational transition of penetration: an α-helix-to-β-sheet transition during 
aggregation and then back to α-helix during the disaggregation process. The use of 
PEGylated lipid vesicles inhibits these conformational transitions. 
In a β-sheet structure, the side chains of involved amino acids are either above or 
below the plane of the β-sheet. The incorporation of a d-amino acid would then 
change the orientation of the side chain from perpendicular to the plane of backbone-
backbone hydrogen bonds into a parallel alignment. The presence of an adjacent pair 
of d-amino acids causes local disturbance in structure and flexibility (27). The degree 
of structural disturbance has been shown to be correlated with the magnitude of the 
secondary structure of the replaced region in the all-L-amino acid peptide (35). Table 
3 summarizes the lipid-induced change in β-structure for all peptides. The largest 
decrease in the magnitude of β-structure formation are observed for the double d-
isomers d19, 20 Aβ(1-40) and d35, 36 Aβ(1-40). Only a minor decrease can be 
observed for d5, 6 Aβ(1-40), which indicates that these amino acids are probably not 
involved in β-structure formation. However, d13, 14 Aβ(1-40) is an exception, 
revealing a slightly increased magnitude of β-structure formation. Our results can 
now compared with structural studies on Aβ(1-40) fibrils. Amyloid fibrils of Aβ(1-
40) are characterized by a specific intermolecular polypeptide assemblies, named 
cross-β structural motif (36). Cross-β structures are defined as extended β-sheet in 
which the plane of β-sheet and the backbone-backbone hydrogen bonds are in linear 
orientation to the fibril axis, while the individual β-strands run perpendicular to the 
fibril axis. The secondary structure of Aβ(1-40) fibrils have been studied by several 
biophysical techniques such as solid-state NMR, hydrogen/deuterium (H/D) exchange 
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and proline-scanning mutagenesis (37-39). In general, the N-terminal residues (1-
10/14) are commonly seen as unordered and are not involved in the fibrils. Another 
common feature of the Aβ(1-40) are 2 β-sheet structure around residues 17-20 and 
30-35. A domain which is different in various models of Aβ(1-40) fibrils is the C-
terminus. While solid-state NMR data suggests that the C-terminus is involved in the 
β-sheet structure (38), proline-scanning mutagenesis analysis and H/D exchange 
indicate a more flexible structure (37, 39).  
Thermodynamic of the Aβ(1-40)-lipid interaction 
All peptides employed have the same sequence with respect to side-chain 
functionality and, in turn similar intrinsic hydrophobicities. In buffer, they adopt a 
predominant random-coil conformation  with minor content of β-structure 
. The electrostatic attraction between the peptides and the anionic lipid 
membrane increases the peptide surface concentration, , probably leading to 
peptide aggregates on the membrane surface as indicated by the increase of β-
structure upon membrane binding. This was previously observed for the Aβ(1-40) 
interaction with nonPEGylated anionic lipid vesicles (22). The incorporation of 
5mol% PEG-lipid in the lipid mixture leads to a polymer brush on the lipid 
membrane surface, which diminishes protein adsorption (40). However, the present 
calorimetric data provide evidence that the peptides penetrate the PEG polymer layer 
and adsorb to the underlying anionic lipid membrane. A useful parameter to evaluate 
the electrostatic effect on the membrane binding is the apparent binding constant, 
, comprising both electrostatic attraction to the lipid membrane and the 
hydrophobic binding into the lipid membrane.  is defined according to  
(70%)
(30%)
Mc
appK
appK
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  (9) 
where  is the molar ratio of bound peptide to total available lipid and is the 
free equilibrium peptide concentration.  is dependent on the peptide 
concentration, and in turn not constant. Furthermore  can now compared with the 
surface partition constant , which correspond to the transfer of the peptide from 
the water-membrane interface into the lipid membrane. For the Aβ(1-40)-membrane 
interaction,  varies between , whereas  is in the range of 
. The large difference between  and  indicates that the 
main factor of membrane binding is the electrostatic attraction of the peptide to the 
negatively charged membrane.  
The hydrophobic peptide binding is purely driven by enthalpy  and is 
almost fully opposed by entropy . This phenomenon is denoted as non-
classical hydrophobic effect which has been also observed for other peptides and 
amphiphilic molecules (41, 42). The large negative entropy contribution is 
remarkable and can be explained by the formation of β-structure associated with 
aggregation on the membrane surface, leading to a higher order of the system. A 
distinct binding thermodynamics was observed for the membrane binding of the β-
structure forming  peptide, which revealed an endothermic binding 
enthalpy  and a positive entropic contribution (25).  
The intercepts of the regression analysis (figure 5) provide the thermodynamic 
binding parameters of a hypothetical Aβ(1-40) peptide that binds to the membrane 
/app b eqK X c=
bX eqc
appK
appK
0K
appK
6 7 13 10 1.2 10 M −⋅ − ⋅ 0K
2 12.7 6.2 10 M− −− ⋅ 0K appK
0( 0)H∆ <
0( 0)S∆ <
3( )KIGAKI
0( 0)H∆ >
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without conformational change and is given by , 
 and . The enthalpy  is endothermic, 
and the adsorption to the membrane is therefore exclusively driven by entropy. 
Similar results were observed for membrane binding of the (random coil)  
peptide (25). The positive entropy term can be explained by the release of hydration 
water  
The ITC experiments further demonstrated pH-dependence of the thermodynamics of 
the Aβ(1-40)-lipid interactions. pH affects the charge of both binding partners. Thus, 
lower bulk pH leads to a lower membrane surface potential , and in turn to a lower 
electrostatic attraction of cationic molecules. On the other hand, the net charge of 
Aβ(1-40) decreases from  at pH 7.0 to  at pH 8.0 as calculated by the 
 values of the charged residues. However, the cluster of basic residues of Aβ(1-
40)  is supposed to be mainly responsible for the electrostatic 
attraction to the anionic lipid membrane. The charge of the cluster decreases from 
 at pH 7.0,  at pH 7.4 to  at pH 8.0, indicating a higher electrostatic 
interaction with the anionic lipid membrane at lower bulk pH. As outlined above, pH 
has a conflictive effect on the oppositely charged binding partners. However, pH 
dependence of the electrostatic interaction can be studied by the contribution of the 
electrostatic free energy to peptide binding which can be calculated according to  
  (10) 
At pH 7.0,  varies between , whereas at pH 7.4  varies 
between . This demonstrates that pH dependence of peptide 
0 1.18 /H kcal mol∆ =
0 0.06 /G kcal mol∆ = − 0 9.8 /S cal molK∆ = 0H∆
3( )KIGAKI
ψ
2.47− 3.6−
apK
13 14 16( )H H and K
1.47 1.21 1.05
0ln( / )el appG RT K K∆ = −
elG∆ 10.8 11.3 /kcal mol− elG∆
10.8 14.4 /kcal mol−
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(cluster) charge has a greater effect on the electrostatic interaction compared to the 
changes in the membrane surface potential. Further, pH affects the aggregation 
behavior of Aβ(1-40) with a reported maximum in the pH range of 4 to 7. However, 
CD experiments have demonstrated a nearly identical conformation of Aβ(1-40) in 
the pH range of 7.0 to 8.0 (data not shown). Changes in the thermodynamic must 
therefore not be ascribed to conformational changes prior the membrane binding. 
Table 2 summarizes the thermodynamic binding parameters of the Aβ(1-40)-lipid 
interaction measured at the three pH values. The molar binding enthalpy  is 
highly pH-dependent. Regression analysis yielded a significant linear correlation in 
the studied pH range with the following equation: 
. A pH deviation of  leads therefore 
to a theoretical change in  of , which is significantly higher than 
the standard deviations at each point. Next, we observed a slightly higher binding 
constant  at pH 7.4 than pH 7.0, whereas the effective charge of the peptide is 
decreased. This can be explained by the fact that less charged molecule bind more 
easily into the hydrophobic lipid membrane.  
Thermodynamics of the β-sheet formation in a membrane environment 
The method of double-d substitution combined with isothermal titration calorimetry 
and CD spectroscopy allows to determine the thermodynamics of β-structure 
formation of Aβ(1-40). Analogous studies were conducted for the membrane-induced 
α-helix formation of magainin and the membrane-induced β-structure formation of 
the KIGAKI peptide (25, 43). The thermodynamics of β-structure formation of Aβ(1-
40) could now be compared with the results obtained for the KIGAKI peptide. 
However, it has been shown that the thermodynamics of the β-structure formation of 
0H∆
0 ( ) 1.8*( 7.0) 18.5 /H pH pH kcal mol∆ = − − 0.1±
0H∆ 1.8 /kcal mol±
0K
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the KIGAKI peptide is dependent of length of the peptide (26). Therefore, it is more 
revealing to compare the obtained results for Aβ(1-40) with those of a hypothetical 
KIGAKI peptide composed of 40 amino acids. In this case, the thermodynamic 
parameters of the β-structure formation are obtained by extrapolation, revealing 
,  and 
. The slope of the regression lines in figure 5 
corresponds to the incremental thermodynamic parameters for β-structure formation 
of Aβ(1-40), and is given by , 
 and . A comparison 
with the values of the 40 amino acids long KIGAKI peptide reveals almost identical 
 values, whereas small deviations can be observed for  and . However, 
the good numerical agreement between Aβ(1-40) and the (hypothetical) 
corresponding long KIGAKI peptide is a strong indication that primarily the peptide 
length than its sequence determine the thermodynamics of the random-coil-to-β-
structure transition in a membrane environment.  
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Figure Captions 
Figure 1. Isothermal titration calorimetry of Aβ(1-40) with SUVs composed of 
POPC/POPG/mPEG 2000 PE (45/50/5mol%). (A) Calorimetric trace obtained by 
titration of 15 mM lipid SUV suspension into 12 µM Aβ(1-40) solution (5mM Hepes 
(pH 7.4)) at 25 °C. Each peak corresponds to the injection of 10 µl SUV suspension. 
(B) Heats of reaction  are plotted versus the injection number . The solid line 
correspond to calculations using the surface partition model combined with 
electrostatic interactions as discussed above 
.  
Figure 2. Binding isotherm of the binding reaction of Aβ(1-40) to lipid SUVs 
composed of POPC/POPG/mPEG 2000 PE (45/50/5mol%) derived from ITC 
experiments. The degree of binding , i.e. molar ratio of bound peptide to lipid 
available for binding, is plotted against the peptide equilibrium concentration . The 
solid line corresponds to the theoretical binding calculated by combining the Gouy-
Chapman theory with a surface partition model using the binding constant 
 and the effective charge .  
Figure 3. (A) CD spectra of Aβ(1-40) and the double d-isomers dissolved in 5mM 
Hepes (pH 7.4). The spectra were recorded at peptide concentrations between 
. (B) CD spectra of Aβ(1-40) and the double d-isomers recorded in 
excess of lipid SUVs composed of POPC/POPG/mPEG 2000 (45/50/5mol%).  
Figure 4. (A) Lipid-induced random coil-to-β-structure transition of Aβ(1-40) 
monitored by circular dichroism (CD) spectroscopy. CD spectra were recorded at 
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lipid-to-peptide molar ratios from 0 to 340. (B) Plot of secondary structure of Aβ(1-
40) versus the lipid-to-peptide molar ratio: β-structure (■) and random coil (●). A 
conformational endpoint of the Aβ(1-40)-lipid interaction could be observed at a 
lipid-to-peptide ratio of 150.  
Figure 5. The thermodynamic parameters of the peptide-lipid interactions are plotted 
against the magnitude of β-structure formation expressed by . (A) The molar 
binding enthalpy (■). (B) Free energy of binding (■) and (●). The 
solid lines (in (A) and (B)) correspond to the regression line. All data were recorded 
at 25 C° in 5mM Hepes (pH 7.4).  
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Appendix 
In this appendix, we show a representative example of a calorimetric and CD 
spectroscopy measurements of the interaction of the four studied double d-isomers of 
Aβ(1-40) with anionic PEGylated lipid vesicles. 
Appendix figure captions 
Appendix figure 1. Structural transition of d5, 6 Aβ(1-40) upon binding to SUVs 
composed of POPC/POPG/PEG (50/45/5 mol%) as monitored by CD spectroscopy. 
CD spectra were recorded in 5 mM Hepes (pH 7.4) at 25 °C. (A) CD spectra with 
varying lipid-to-peptide molar ratios between 0 and 396. (B) Fraction of secondary 
structure was plotted vs. the corresponding lipid-to-peptide molar ratios: (■) β-
structure and (●) random coil and (▲) α-helix.  
Appendix figure 2. (A) Experimental heat flow obtained by the injection of anionic 
SUVs (POPC/POPG/ mPEG 2000 PE (50/45/5 mol%) into a 6.2 µM d5, 6 Aβ(1-40) 
solution at 25 °C. (B) Binding isotherm derived from the ITC experiment displayed in 
(A). The solid line corresponds to the best fit of the surface partition model. 
Appendix figure 3. Conformational change of d13, 14 Aβ(1-40) upon binding to 
SUVs composed of POPC/POPG/ mPEG 2000 PE (50/45/5 mol%) as measured by 
CD spectroscopy. CD spectra were recorded in 5 mM Hepes (pH 7.4) at 25 °C. (A) 
CD spectra with varying lipid-to-peptide molar ratios between 0 and 543. (B) 
Fraction of secondary structure was plotted vs. the corresponding lipid-to-peptide 
molar ratios: (■) β-structure and (●) random coil and (▲) α-helix.  
Appendix figure 4. (A) Heat flow obtained by the injection of anionic SUVs 
(POPC/POPG/ mPEG 2000 PE (50/45/5 mol%)) into a 10.1 µM d13, 14 Aβ(1-40) 
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solution at 25 °C. (B) Binding isotherm derived from the ITC experiment displayed in 
(A). The solid line corresponds to the best fit of the surface partition model. 
Appendix figure 5. Conformational change of d19, 20 Aβ(1-40) upon binding to 
SUVs composed of POPC/POPG/ mPEG 2000 PE (50/45/5 mol%) as observed by 
CD spectroscopy. CD spectra were recorded in 5 mM Hepes (pH 7.4) at 25 °C. (A) 
CD spectra with varying lipid-to-peptide molar ratios between 0 and 495. (B) 
Fraction of secondary structure was plotted vs. the corresponding lipid-to-peptide 
molar ratios: (■) β-structure and (●) random coil and (▲) α-helix.  
Appendix figure 6. (A) Heat flow obtained by the injection of anionic SUVs 
(POPC/POPG/ mPEG 2000 PE (50/45/5 mol%) into a 12.5 µM d19, 20 Aβ(1-40) 
solution at 25 °C. (B) Binding isotherm derived from the ITC experiment displayed in 
(A). The solid line corresponds to the best fit of the surface partition model. 
Appendix figure 7. Conformational change of d35, 36 Aβ(1-40) upon binding to 
SUVs composed of POPC/POPG/ mPEG 2000 PE (50/45/5 mol%) as observed by 
CD spectroscopy. CD spectra were recorded in 5 mM Hepes (pH 7.4) at 25 °C. (A) 
CD spectra with varying lipid-to-peptide molar ratios between 0 and 325. (B) 
Fraction of secondary structure was plotted vs. the corresponding lipid-to-peptide 
molar ratios: (■) β-structure and (●) random coil and (▲) α-helix.  
Appendix figure 8. (A) Heat flow obtained by the injection of anionic SUVs 
(POPC/POPG/ mPEG 2000 PE (50/45/5 mol%)) into a 10.9 µM d19, 20 Aβ(1-40) 
solution at 25 °C. (B) Heats of reaction derived from the ITC experiment displayed 
in (A) were plotted vs. the injection number .  
jh
jn
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3. Amyloid-β peptide interaction with 
glycosaminoglycans 
Summary 
Alzheimer’s disease (AD) is a progressive, neurodegenerative disorder affecting 
around 25 million people worldwide. A major pathological hallmark of the disease 
are extracellular amyloid plaques, mainly composed of aggregated amyloid-β peptide 
(Aβ). Several other components are colocalized with the amyloid plaques, including 
glycosaminoglycans (GAGs) and proteoglycans (PG). GAGs are long, unbranched 
polysaccharides composed of a repeating disaccharide unit, which are covalently 
attached to the core protein of PGs. In vitro, GAGs and PGs have the ability to 
accelerate Aβ aggregation, suggesting the involvement of the Aβ-GAG/PG 
interaction in the Aβ aggregation process in vivo. Here, we have studied the binding 
equilibrium between Aβ(1-40) and heparin with isothermal titration calorimetry. 
Calorimetric data reveals a high affinity of Aβ(1-40) to heparin with a microscopic 
dissociation constant , a reaction enthalpy  and a 
peptide-to-heparin stoichiometry  under the present experimental conditions 
(5 mM sodium acetate (pH 3.7)) at 25 °C. The obtained binding stoichiometry equals 
charge neutralization, which emphasize the electrostatics of the Aβ(1-40)-heparin 
interaction. However, temperature dependence studies reveals a negative heat 
capacity change of , indicating that also hydrophobic and other 
interactions are involved in the binding equilibrium. Circular dichroism (CD) 
spectroscopy reveals a conformational change of Aβ(1-40) from random-coil to β-
12.1dK nM=
0 6.3 /AH kcal molβ∆ = −
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structure in the presence of heparin at pH 3.7. Studies with double d-isomers of Aβ(1-
40) demonstrates that cluster of basic amino acids in the N-terminal domain, His13-
His14-Gln15-Lys16, plays an important role in the Aβ(1-40)-heparin interaction. At 
physiological pH, CD measurements reveal no heparin-induced structural change of 
Aβ(1-40), suggesting that interaction is abolished at this pH. 
Manuscript: Amyloid-β peptide interaction with glycosaminoglycans 
Introduction 
Alzheimer’s disease (AD) is the major form of dementia with an estimated worldwide 
prevalence of 24 million people in 2005 (1). The increase of the life expectancy and 
the fact that a major risk factor for AD is age will even increase the impacts of the 
disease. In 2040, 81 million affected people are predicted with the highest increase 
rates in India, China, and their south Asian and western Pacific neighbours (1). 
Clinically, AD is characterized by the progressive loss of cognitive abilities and 
behavioral changes. One pathological hallmark of AD are extracellular amyloid 
plaques in the brain, mainly composed of amyloid fibrils formed by the amyloid-β 
peptide (henceforth called Aβ). Aβ is a 39-42 amino acid long peptide, derived from 
proteolytic cleavage of the membrane-bound amyloid precursor protein (APP) (2). In 
fibrils, Aβ exhibit a characteristic cross β-structure, in which the individual β-strands 
run perpendicular to the fibril axis (3). Soluble, monomeric Aβ has been 
demonstrated to be a normal component of the cerebro spinal fluid (CSF) and the 
blood plasma (4-6). In vitro, Aβ tends to aggregate into a polymorphic solution, 
including monomers, oligomers and fibrils. The aggregation process occurs in a 
nucleation-dependent manner (7), such as crystallization, and is highly dependent on 
pH (8), salt concentration (9) and nature of buffer (10). A nucleation-dependent 
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process is characterized by a nucleation phase, in which the peptide undergoes a 
series of thermodynamically unfavorable association steps to form a nucleus. After 
the nucleus is formed, further association steps become thermodynamically favorable, 
resulting in a rapid growth phase. Typically, oligomers are not observed until the 
monomer concentration exceeds the so-called critical concentration. In literature, 
different values of the critical concentration of Aβ are reported, probably due to 
differences in the chemical treatment of the peptide, physicochemical conditions such 
as pH and salt concentrations and the applied measurement techniques. At pH 7.4, 
critical concentration values of  (11) and  (12) were reported. 
However, the concentration of Aβ in vivo has found to be in the low subnanomolar 
range both in the healthy and diseased brain (4-6). Thus, the discrepancy between the 
in vivo concentration of Aβ and its critical concentration in vitro is at least four orders 
of magnitude. Several mechanisms are proposed to overcome this concentration 
discrepancy, including the interaction of Aβ to proteoglycans (PG) and 
glycosaminoglycans (GAGs). GAGs are long, unbranched polysaccharide composed 
of a repeating disaccharide unit, which are covalently attached to the core protein of 
PGs. The involvement of PG and GAGs in AD is mainly based on the findings that 
both components are found in amyloid plaques (13). In vitro experiments 
demonstrated that Aβ binds with high affinity to GAG (14) and that this interaction is 
dependent on both the pH and the fibrillar state of the Aβ (15, 16). To what extent Aβ 
interacts with GAGs or PG at physiological pH is still controversial. While some 
investigators report that Aβ interacts with GAG at physiological relevant (7.0) or 
even higher pH (17, 18), others claim that Aβ interacts with GAG only in its fibrillar 
state at physiological pH (15). Therefore, the question remains open whether Aβ-
6 9 Mµ− 40 Mµ
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GAG interaction is an putative nucleation mechanism or that if follows only after Aβ 
fibrillization. However, the interaction of PG with Aβ inhibits the proteolytic 
breakdown of amyloid fibrils, contributing to the accumulation and persistence of 
amyloid plaques (15). Further, it was demonstrated that the Aβ fibrillization is 
accelerated by the presence of PG, and that this acceleration is mainly mediated by 
the sulphate groups of the GAG (19) 
In this study, we investigated the Aβ(1-40)-GAG interaction, using heparin as GAG 
molecule. Using isothermal titration calorimetry (ITC), we investigated the 
thermodynamic details of the binding reaction, and report here the microscopic 
binding constant , the stoichiometry  and the reaction enthalpy . CD 
spectroscopy was applied to give insights into the structural aspects of the binding 
interaction. Finally, double d-isomers of Aβ(1-40) were used to study the existence of 
a molecular recognition site for the Aβ(1-40)-GAG interaction.  
Material and Methods 
Aß(1-40) was purchased from rPeptide (Bogart, GA, USA). The double d-isomers 
were kindly provided by Dr. M. Beyermann from the Leibniz-Institute of Molecular 
Pharmacology, 13125 Berlin, Germany. Unfractionated heparin (sodium salt, from 
porcine intestinal mucosa, average ) was purchased from Celsus 
Laboratories (Cincinnati, OH). All other chemicals were purchased from commercial 
sources at the highest purity.  
Peptide solution preparation 
Aβ(1-40) has been observed to exhibit significant experimental differences, 
depending on the manufacturer and even between different batches of the same 
K n 0H∆
13000rM 
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supplier. To decrease the variation between different batches, Aβ(1-40) and its double 
d-isomers were dissolved in hexafluoroisopropanol (HFIP) at 0.5 mg/ml and the stock 
solution was equilibrated for 1 h. The treatment with HFIP removes any pre-existing 
aggregates and defines a common chemical starting point. Aliquots of the stock 
solution were stored in glass tubes. HFIP is first removed by the means of gentle 
stream of nitrogen and by subsequent overnight vacuum. The samples were stored at 
a temperature of -20°C. For measurements, the appropriate volume of buffer was 
added. To accelerate the peptide solubilization, the peptide solution was sonicated for 
a short period of time.  
Circular dichroism (CD) spectroscopy 
CD measurements were performed on a Chirascan CD spectrometer (Applied 
Photophysics Ltd., Leatherhead, UK). Spectra were recorded from 250 nm to 190 nm, 
with a resolution of 1 nm, a response time of 20 s and a bandwidth of 1 nm. Unless 
noted otherwise, a quartz cuvette with a path length of 0.1 cm was used. Results are 
reported as mean molar residue ellipticities in units of deg cm2 dmol-1. The 
percentage of peptide secondary structure was estimated from a computer simulation 
based on the reference spectra obtained by Reed and Reed (20). 
Isothermal titration calorimetry (ITC) 
ITC was performed on a VP ITC calorimeter (MicroCal, Northampton, MA). To 
avoid air bubbles, all solutions were degassed in vacuum for  immediately 
prior use. Raw data were processed using the Origin software provided with the 
instrument.  
10min
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Evaluation of calorimetric data 
Calorimetric data were analyzed by a three-parameter nonlinear least-squares fitting 
(NLSF) in which the sum of squared residuals (SSR) is minimized. The fitting 
procedure was conducted in a Microsoft Excel worksheet using the Solver add-in. 
The confidence of the fitted parameters were determined with the help of SSR plots 
as described elsewhere (21). The parameters ΔH° and n exhibit SSR plots with a clear 
minimum and steep slopes on both sides and can therefore be determined with high 
confidence. However, the SSR plot of the parameter K generally reveal a minimum 
with a smooth slope to higher K values (maximal calculated K of ), which 
preclude the determination of the parameter K with high confidence. For the best fit 
values of K we quote the minimum of the SSR plot.  
Peptide concentration determination 
Aβ(1-40) and its double-d-isomers do not contain a Trp residue, therefore the peptide 
concentration cannot be calculated using UV absorbance at 280 nm. Alternatively, the 
peptide concentration was determined by amino acid analysis. The amino acid 
analysis was conducted by the Protein Analytical Service facility of the University of 
Bern. The tubes for the analysis contain 50µl of the peptide-HFIP solution 
(0.5mg/ml). The tubes were first dried at RT and then overnight in vacuum.  
Results 
Conformation of Aβ(1-40) in aqueous solution 
The aggregation of Aβ(1-40) is dependent on the peptide concentration itself and the 
physical-chemical environment such as pH, temperature, pressure, buffer and salt. 
Using Circular dichroism (CD) spectroscopy, we tested the effect of physical-
9 110 M −
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chemical parameters on the conformation of freshly dissolved Aβ(1-40). First, the 
effect of low pH values was studied. Figure 1 displays CD spectra of Aβ(1-40) 
dissolved in 5 mM sodium acetate with varying pH values from 3.7 to 4.2. At pH 3.7, 
CD spectrum exhibits a minimum at 198 nm indicating a mainly random coil 
conformation. As shown in figure 1A, the ellipicity at 198 nm is decreased with 
increasing pH values. An isobestic point could be observed at 211 nm indicating a 
two state transition. CD spectra were analyzed as described in the method section and 
the resulting fractions of secondary structure are displayed in Figure 1B. The content 
of α-helix remained constant at around 3% (not shown). The increase of pH from 3.7 
to 4.2 resulted in an increase of β-structure by 13.2%, while the random coil content 
decreased by the same magnitude.  
Figure 2 shows the salt influence of increasing NaCl concentrations on the CD 
spectra of Aβ(1-40) in 5 mM sodium acetate (pH 3.7) . The NaCl concentration was 
gradually increased from 0 to 20 mM and finally up to 100 mM. With the addition of 
NaCl, the elliptictiy at 198 nm decreased and became positive. A new minimum at 
220 nm was observed, which is a characteristic of β-structure. The isosbestic point 
observed at 212 nm indicates again a two-state random coil-to-β-structure transition. 
Figure 2B shows a plot of secondary structure against the NaCl concentration. The 
addition of 20 mM NaCl increased β-structure content by 22%, while additional 80 
mM NaCl only led to a further increase of 8%. Compared to NaCl, even stronger 
effects were observed with NaSO4 whereas KCl induced a less pronounced effect (at 
identical ionic strength, data not shown).  
Finally, the effect of both temperature and increasing concentration of sodium acetate 
(pH 3.7) on the secondary structure of Aβ(1-40) were studied. CD spectra revealed no 
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significant structural changes within the measured range of buffer (5 mM to 25 mM) 
(figure 3) and temperature (18-32°C) (data not shown). Further, the CD spectrum of 
Aβ(1-40) in 25 mM sodium acetate (pH 3.7) remains constant within 12 hours. 
Heparin-induced conformational change of Aβ(1-40) 
We performed CD measurements to monitor the structural changes of Aβ(1-40) upon 
binding to heparin. CD spectra were recorded in 5 mM sodium acetate (pH 3.7) at a 
peptide concentration of 15 µM and were titrated with a 28 µM heparin solution. The 
corresponding spectra are displayed in figure 4. An isosbestic point could not be 
observed for all spectra, indicating the involvement of more than two structural 
species.  
CD spectra were divided depending on their heparin-to-Aβ(1-40) ratio (r) in into a 
low, intermediate and high heparin region. In absence of heparin, CD spectra of 
Aβ(1-40) shows a predominant random-coil conformation (66%) with some β-
structure (33%). The addition of low amount of heparin (r=0-0.05) induced a random-
coil-to-β-structure transition with an observed isosbestic point at 211 nm as shown in 
figure 4A. At a heparin-to-Aβ(1-40) ratio of 0.05, the CD spectra of Aβ(1-40) reveals 
a high content of β-structure (70%), while the content of random coil is 29%. This 
corresponds to an increase of β-structure by 37%. For heparin-to-Aβ(1-40) ratios of 
r=0.06-0.12, the spectral minimum is increased from  
and shifted from 222 nm to 225 nm as displayed in figure 4B. In this intermediate 
region, the CD spectra could not be used to calculate the secondary structure. A 
possible explanation for this phenomena could be the interfering scattering by the 
presence of aggregates formed by the cross-linking of heparin molecules via Aβ(1-
40), which was previously observed for the interaction of the peptide TAT-PTD with 
2 13855 1258 degto cm dmol−− −
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heparan sulfate (22). Further addition of heparin brings the aggregates again in 
solution, as indicated by the CD spectra exhibiting a minimum at 220 nm and with 
ellipticities of . This corresponds to an increase of β-
structure from 80% to 85% within this region.   
Binding of Aβ(1-40) to heparin 
Isothermal titration calorimetry (ITC) is an established method for the 
thermodynamic characterization of a binding reaction. Here ITC was applied to study 
the binding of Aβ(1-40) to heparin. A typical ITC experiment is shown in figure 5A. 
The ITC cell contained a 15 µM Aβ(1-40) solution which was titrated with 4 µl 
aliquots of a 28 µM heparin solution. Aβ(1-40) and heparin were both dissolved in 5 
mM sodium acetate (pH 3.7). The heat flow of the injection peaks was integrated 
yielding the heat of reaction  for the i injection. As illustrated in figure 5A,  are 
initially exothermic, with an abrupt change to zero, before becoming endothermic. In 
the end of the calorimetric experiment,  approaches slowly zero. We assume that 
the all Aβ(1-40) were bound to heparin, as the heats of reaction become first zero. 
The endothermic heats in the end of the ITC experiment are assigned to lateral 
aggregation of small fibrils and/or crosslinking of heparin molecules. As a control 
experiment, heparin solution was titrated in buffer solution obtaining small heat peaks 
(not shown), which were included in the evaluation. For a better analysis of the 
calorimetric data, the maximal endothermic heat of reaction was subtracted from all 
. The corrected heats of reaction are denoted as  and can be plotted against the 
heparin-to-Aβ(1-40) molar ratio as displayed in figure 5B. The molar binding 
2 14700 5870degto cm dmol−− −
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enthalpy of Aβ(1-40), , can be directly derived from the ITC experiment and is 
calculated according to, 
  (1) 
where is the molar amount of Aβ(1-40) in the calorimetric cell and is the 
cumulative heat of reaction (the final endothermic heats of reaction were not 
considered). For the ITC measurement in figure 5, a molar binding enthalpy of 
was determined.  
As shown in figure 5B, the first few injections of heparin lead to rather constant heats 
of reaction with . In the beginning of the ITC measurement Aβ(1-40) 
is in excess over heparin and complete binding of the injected heparin to Aβ(1-40) 
can be assumed. The molar heat of reaction of heparin can be calculated as 
, where  is the 
molar amount of injected heparin. The number of bound Aβ(1-40) per heparin 
molecule can be derived by the ratio , yielding a binding stoichiometry 
 of 16.6. To obtain the binding constant K and therefore complete the 
thermodynamic characterization of the Aβ(1-40)-heparin interaction, the binding 
isotherm was analyzed using the multisite binding model. In the multisite binding 
model, a macromolecule such heparin has n binding sites of identical affinity to a 
ligand and binding occurs in a noncooperative way. The characteristic equation of the 
model is (23): 
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AH β∆
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  (2) 
 where n is the average number of Aβ(1-40) bound to a heparin molecule, K is the 
microscopic binding constant to each binding site of heparin. In the following, the 
indices t, f and b stand for the total, free and bound concentration of the compound in 
parentheses. In equation , the concentration of free Aβ(1-40), , can be replaced 
by the term  using the mass conservation. Simple 
mathematical rearrangements lead to a quadratic equation,  
 (3) 
, which gives us the following expression of the concentration of bound Aβ(1-40), 
, 
 (4) 
The total concentration of Aβ(1-40), , is adjusted after each injection. The 
concentration of bound Aβ(1-40), , is linked to the experimental ITC data 
according the following equation, 
  (5) 
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where is the molar binding enthalpy of Aβ(1-40) , is the change of 
concentration of bound Aβ(1-40) in the ith injection and is the volume of the 
calorimetric cell.  
The data in figure 5 can now be fit using a three-parameter nonlinear least-square 
fitting (NLSF), obtaining the following parameters for the best fit: 
. The fit values of n and are in 
good agreement to those determined by simple calculations from the calorimetric data 
( . see above). The knowledge of the binding constant 
 allows the calculation of the free energy of binding ( ) and 
the change in entropy ( ). 
A sulfur content of 12.4% was determined for a different batch of heparin obtained 
from the same manufacturer (24). Based on this sulfur content, the average 
disaccharide unit of the used heparin has a molecular weight of  and bears 
a charge of . Therefore, an average heparin molecule has an estimated charge 
of . On the other hand, Aβ(1-40) has a net charge of +5.14 at pH 3.7. Charge 
neutralization is fulfilled at a binding stoichiometry  of . The binding 
stoichiometry obtained from the calorimetric data therefore equals charge 
neutralization. 
ITC measurements were also performed at 18 °C and 32 °C. Within this temperature 
range conformation of Aβ(1-40) is nearly constant as shown previously. Differences 
in the thermodynamics are thus not caused by structural differences of Aβ(1-40). All 
thermodynamic parameters measured at the three temperatures are summarized in 
0
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table 1. The binding stoichiometry of the Aβ(1-40)-heparin varied between 14.1 to 
18.2 with increasing values at higher temperature. Moreover, the reaction enthalpy 
became more negative at higher temperature. The decrease was linearly dependent on 
temperature as displayed in figure 6. The molar heat capacity change is 
 (slope of the regression line) and indicates a 
hydrophobic contribution to the binding process. The temperature dependence of the 
binding constant can be calculated with vant’t Hoff’s law, , using 
the experimentally determined temperature dependence of the molar reaction 
enthalpy as . In figure 7, the dots 
correspond to the experimentally determined constants whereas the solid line shows 
the predicted temperature-dependence of the binding constant (using the 
experimentally determined binding constant at 25 °C). At 32 °C, the experimental 
binding constant is in good agreement with the predictions. However, a large 
discrepancy is found at 18 °C, which must be ascribed to particular difficulty in 
determine the binding constant from the calorimetric data at this temperature.  
Comparision of Aβ(1-40) with double-d isomers 
We have used a set of four double d-isomers of Aβ(1-40) to study the structural 
aspect of the Aβ(1-40)-heparin interaction. In the sequence of the double d-isomers 
two adjacent amino acids are substituted by their corresponding d-enantiomers. The 
double-d-amino acid substitution has been shown to lead to local disturbance of their 
secondary structure without altering other physical characteristics such as 
hydrophobicity or side-chain functionality (25). Figure 8 displays the CD spectra of 
the peptides in buffer (5mM sodium acetate (pH 3.7)) and upon binding to heparin. 
0 1 1
, 167P AC cal mol Kβ
− −∆ = −
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d K H RT
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0 0 0
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While all peptides adopt a mainly random coil structure in aqueous solution, they fold 
to β-structure upon binding to heparin. Further, ITC measurements were performed 
for Aβ(1-40) and its double d-isomers in 5mM sodium acetate (pH 3.7) at 25°C and 
the thermodynamic binding parameters are summarized in table 2. All double d-
isomers of Aβ(1-40) bind with high affinity to heparin as indicated by high binding 
constants (the corresponding dissociation constants are in the nanomolar range). 
Three double d-isomers, namely d5, 6, d19, 20 and d35, 36 Aβ(1-40), have 
dissociation constants which are slightly lower than the measured  
for Aβ(1-40). In contrast, d13, 14 Aβ(1-40) has a less high affinity to heparin 
indicated by a higher -value of 14.0 ± 7.4 nM. All double d-isomers reveal a 
smaller stoichiometry n in comparison to Aβ(1-40), with n varying between
. The binding of all double d-isomers to heparin is an exothermic reaction 
as indicated by negative binding enthalpies . Compared to Aβ(1-40), the double 
d-isomer d5, 6 exhibits identical -values, while the d13, 14 has smaller, and 
d19, 20 and d35, 36 larger negative -values.  
Electrostatic of Aβ(1-40) –heparin interaction 
Protein-polyelectrolyte interactions, such as the interaction of Aβ(1-40) with heparin, 
are strongly dependent on the salt concentration of the solution (26). A popular model 
to describe the salt dependence of the binding constant of protein to polyelectrolyte is 
the oligolysine model (27). The basis of this model is the counterion condensation 
which predicts that the charge of a polyelectrolyte such as heparin is partly 
neutralized by counterion condensation (28). The oligolysine model states that when 
ligand binding to a polyelectrolyte is accompanied by the penetration of z-charged 
5.6 0.8dK nM= ±
dK
7.0 13.9to
0H∆
0
AH β∆
0
AH β∆
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residues into the condensed counterion layer, in turn, z condensed counterions are 
released into the bulk solution. For ligand-heparin interaction, the salt-dependence of 
the observable binding constant is expressed by the following equation (27), 
 (6) 
where  contains all physical contribution to binding other than counterion 
release and is assumed to be independent on the salt-concentration.  is 
predicted to be linearly dependent on the logarithm of the salt concentration with 
slope . The value of z is obtained by determining the 
slope in a log-log plot of the experimentally determined binding constant versus 
the salt concentration . To test the electrostatic effect on the thermodynamic 
parameters, the usual procedure is to gradually increase the salt concentration of the 
buffer solution. In the case of Aβ(1-40) at pH 3.7, the presence of salt immediately 
induces the aggregation process of Aβ(1-40), as indicated by the observed random-
coil to β-structure transition of Aβ(1-40). As discussed above, the binding constant 
 can only be properly derived from the calorimetric data when Aβ(1-40) is in a 
monomeric state. Therefore, this approach is not suitable to study the salt-dependence 
of the Aβ(1-40)-heparin interaction. However, at pH 3.7, we observed that CD 
spectra of Aβ(1-40) are identical in a sodium acetate concentration range of 5 to 25 
mM. Sodium acetate is formed by dissolving acetic acid into water with subsequent 
adjusting of pH by addition of NaOH. Using the pKa value of acetic acid 
( ), the concentration of sodium ions in the buffer solution can be 
calculated, resulting in 0.07, 0.28 and 0.43 mM for 5, 15 and 25 mM sodium acetate 
0log log 0.01 0.434 logobsK K z z M
+ = + − −  
0log K
log obsK
[ ]log / logobsd K d salt z= −
obsK
[ ]salt
K
4.79apK =
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(pH 3.7). Although the concentration range of sodium is very small, ITC 
measurements were performed for three buffer concentrations (5, 15 and 25 mM) and 
the thermodynamic parameters are summarized in table 1. However, regression 
analysis of a  plot yields a linear correlation with slope -0.75 (not 
significant). Nevertheless, the obtained z value of -0.75 is used as a rough prediction 
for the number of positively charged residues of Aβ(1-40) penetrating the condensed 
counterion layer of heparin. However, this z value is much smaller than the nominal 
net charge of Aβ(1-40) at pH 3.7 (+5.14). Discrepancy between z values and the 
nominal peptide charge were observed for oligolysine and to a much greater degree 
for the 26-amino-acid long peptide mellitin and can be ascribed to the flexibility of 
the peptide main and side chains(27, 29). By using equation (6) and , the 
salt-dependence of the binding constant of Aβ(1-40)-heparin interaction can now 
calculated and is displayed in figure 9. The binding constant decreases with 
increasing salt concentration and is reduced to  at physiological 
salt concentration (140mM). Same calculations were performed for z-values of 2.5 
and 5, which corresponds to half and the whole net charge of the peptide at pH 3.7 
and are also displayed in figure 9.  
Aβ(1-40)-heparin interaction at physiological pH 
CD spectroscopy was applied to examine the abiltiy of heparin to induce a structural 
transition of Aβ(1-40) at physiological pH. Aβ(1-40) was dissolved in 5mM Hepes 
(pH 7.4) containing 0 or 140 mM NaF. Hepes buffer was used instead of phosphate 
buffer, as phosphate buffer was reported to specifically shield electrostatic 
interactions which are important for the Aβ(1-40)-heparin interaction (17). NaF was 
preferred to NaCl in order to avoid excessive light absorption by the chloride ions 
log logobsK Na
+ −  
0.75z = −
5 18.74 10obsK M
−= ⋅
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below 200 nm. Aβ(1-40) and heparin were mixed (1:1, m:m) and CD spectra of the 
peptide and the mixture were recorded at 0, 24, 48 and 96 hr for the two buffer 
conditions. In the absence of salt, CD spectra of Aβ(1-40) showed a predominant 
random-coil conformation and remained constant over the observed time range, as 
displayed in figure 10A. For the Aβ(1-40)-heparin mixture, virtually identical CD 
spectra were observed (figure 10B), leading to the conclusion that heparin cannot 
induce a structural transition of Aβ(1-40) at physiological pH. 
In the presence of NaF, CD spectra of Aβ(1-40) exhibit a minimum at 200 nm, 
indicating a mainly disordered conformation as displayed in figure 10C. However, the 
spectra show a high variation, which is best illustrated by the varying values of the 
minimal ellipticity at 200 nm from . These 
variations, however, cannot be correlated with the time point of recording, as e.g. the 
spectra recorded at 72 hr shows the lowest minimal ellipticity at 198 nm. Similar 
results were obtained for the Aβ(1-40)-heparin mixtures (figure 10D). Here, CD 
spectra showed a minimum at 200 nm which are slightly increased in comparison to 
the spectra of Aβ(1-40) alone. However, the differences are not large enough to 
conclude that addition of heparin lead to a structural conformation change of Aβ(1-
40). 
 
Discussion 
We studied the interaction of Aβ(1-40) with heparin over a broad range of pH and salt 
concentrations, including the physiological range. Isothermal titration calorimetry 
(ITC) is a valid and often used method to study binding interactions, including 
2 117569 11608degto cm dmol−− −
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peptide-glycosaminoglycan interactions (24, 30). ITC experiments provide the whole 
binding isotherm in a single experiment. However, the binding constant , and 
therefore , can only be derived from the calorimetric data by using a specific 
binding model. Binding models, including the multisite binding model applied here, 
require the exact concentrations of both binding partners. While the handling of 
heparin is uncomplicated, Aβ(1-40) tends to aggregate in aqueous solution forming a 
polydispersed solution, including monomers, oligomers and fibrils. The concentration 
of such a solution cannot be determined. Therefore, Aβ(1-40) must be monomeric in 
order to obtain the binding constant from the calorimetric data. As a typical ITC 
experiments is normally finished in 60 to 90 min (including the calibration time), 
Aβ(1-40) should be monomeric and stable over this time range.  
Aβ(1-40) in aqueous solution 
The effect of varying pH and salt content on the conformation of freshly dissolved 
Aβ(1-40) was investigated by CD spectroscopy. Monomeric Aβ(1-40) produces a CD 
spectrum which is characterized by a high content of random coil and minor content 
of β-structure (31). Our CD measurements indicate that even small pH changes (0.1) 
in the pH range of 3.7 to 4.2 immediately change the Aβ(1-40) aggregation pattern, as 
illustrated by the increase of β-structure content of the freshly dissolved peptide. 
Analogous results were obtained when the pH was gradually decreased from 7.2 to 
6.4 (phosphate buffer, data not shown). These data are consistent with previous 
observations of a more pronounced aggregation of Aβ(1-40) in the pH range of 4 to 7 
(8). Specific charge-charge interactions between carboxylate groups of glutamate and 
aspartate residues and imidazolium of histidine residues have been proposed to 
account for the pH dependence of the Aβ(1-40) fibrillization (32, 33). Additionally, 
K
0G∆
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salt bridges between D23 and K28 and K16 and E22 have been identified in amyloid 
fibrils, supporting the importance of charge-charge interactions (34). However, it was 
also claimed that these favorable charge-charge interactions are not essential for the 
Aβ(1-40) fibrillization (35). Here, we suggest that the diminishing electrostatic 
repulsion of the peptides near the isoelectric point plays the major role in the pH 
dependence of the Aβ(1-40) fibrillization.  
We have also shown that the addition of salt induces a conformational transition from 
random coil to β-structure at pH 3.7. This indicates that the presence of salt favors the 
aggregation of Aβ(1-40) even at relative low salt concentration (5 mM). Our 
observations are in line with a previous study showing the positive effect of salt on 
the Aβ(1-40) aggregation process (9). It was concluded that salt affects the 
aggregation of Aβ(1-40) by a combination of specific ion-peptide interactions and a 
change of water structure, whereas unspecific Debye-Hückel screening was excluded. 
However, no change of the conformation of the freshly dissolved peptide was 
observed in the corresponding study (9). It is noteworthy to mention that all data of 
this study were measured at pH 9.0. To exclude differences due to differences in 
peptide source and sample preparations, similar CD measurements were conducted at 
pH 7.0 and 8.0. Indeed, CD experiments do not show any conformational change of 
Aβ(1-40) within 24 hr. Therefore, salt increases the kinetic of the aggregation process 
in a much greater extent at pH 3.7 compared to pH 7.0 (or 8.0). Both pH values 
represent the edge of the pH-dependent aggregation maximum of Aβ(1-40), and can 
be seen as equal vulnerable for aggregation. The reason for the immediate salt-
induced conformational transition at pH 3.7 remains elusive. 
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However, our data clearly demonstrate that pH and salt can affect the aggregation 
properties of an Aβ(1-40) solution. In the pH range between 3.8 and 7.0, the Aβ(1-40) 
cannot be assumed as monomeric. This might be insignificant for certain questions 
and techniques, however, it is not for the study of the thermodynamics of the heparin-
Aβ(1-40) interaction. As discussed above, the binding constant K can only be derived 
from the calorimetric data, when Aβ(1-40) is monomeric. Therefore, the strong 
dependence of the Aβ(1-40) aggregation on its physical-chemical environment, 
particular pH and salt concentration, limits the condition, in which we can properly 
study the Aβ(1-40)-heparin interaction by ITC.  
Binding of Aβ(1-40) to heparin  
Isothermal titration calorimetry shows that under the present experimental conditions 
(pH 3.7, no salt) monomeric Aβ(1-40) binds with high affinity to heparin with a 
dissociation constant of  at 25 °C. Further, calorimetric data also 
demonstrate that heparin has multiple independent binding site for Aβ(1-40). Both 
negative  and positive  contribute to the free energy of binding reaction in 
the studied temperature range (18-32 °C). At 18 °C, the entropic contribution 
amounts to 56% of the total free energy, which decrease with increasing temperature 
to 40% at 32 °C. The positive entropy can be explained by the release of hydration 
water, which is further supported by the negative molar heat capacity . A 
negative molar heat capacity generally indicates the involvement of hydrophobic 
interaction. However, the obtained stoichiometry is equivalent to charge 
neutralization of heparin by Aβ(1-40), which indicates the importance of electrostatic 
interactions. Generally, the interaction of ligands to glycosaminoglycans is 
12.1dK nM=
0H∆ 0T S∆
0
,P AC β∆
Chapter 3  
- 79 - 
considered to be electrostatic in nature, although other types of interactions may also 
occur (36). 
The binding of Aβ(1-40) to heparin entails two processes: 1) association with the 
GAG molecule and 2) the structural transition to β-structure. Membrane binding 
studies using double d-isomers of Aβ(1-40) have demonstrated that the membrane-
induced β-structure formation of Aβ(1-40) is an exothermic process with a -
value of  (chapter 2). Structural data have shown that he 
binding of Aβ(1-40) to heparin is associated with an increase of β-structure of 36% 
which corresponds to 14 amino acids changing from random coil to β-structure. 
Therefore, the contribution of the β-structure formation to the binding enthalpy is in 
the range of . An additional exothermic contribution to the enthalpy 
comes from the electrostatic interactions between the positively charged amino acids 
and the sulfur groups. Thus, the theoretically expected enthalpy is much lower than 
the experimentally determined . However, a possible 
explanation for this differences could be that the β-structure formation in the heparin-
Aβ(1-40) system is less exothermic compared to the membrane environment. This 
could be possible, since the thermodynamic of the β-structure formation has been 
shown to be highly dependent on the solvent (37). A similar observation was made 
for the GAG binding of the melittin (29). The binding of the peptide is accompanied 
by a structural transition from random-coil-to-α-helix. In aqueous solution, the helix 
formation is an exothermic process with an enthalpy of 
, whereas in the melittin-GAG system it was reported close to zero.  
Hβ∆
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In the case of Aβ(1-40), the cluster of basic amino acids in the N-terminal domain, 
His13-His14-Gln15-Lys16, has been suggested to interact with glycosaminoglycans. 
This is primarily due to the cluster of positive charged amino acids, but also to its 
resemblance with the proposed consensus motif, BBXB (B is basic residue) for the 
heparin binding site on proteins (38). Further, it has proposed that the basic amino 
acids of Aβ(1-40)  has to assume a specific conformation for glycosaminoglycans 
binding (39). However, to examine the existence of a molecular recognition for the 
Aβ(1-40)-heparin interaction, double d-isomers of Aβ(1-40) were studied. The main 
advantage of double-d substitution is that it does not alter important physical-
chemical properties such as net charge, hydrophobicity and side-chain functionality 
(25). The site of double-d-substitutions were located in the N-terminal domain in the 
case of d5, 6 Aβ(1-40), in the putative glycosaminoglycan-binding site (d13, 14 
Aβ(1-40) ) and in region presumably involved in the β-structure (d19, 20 and d35, 36 
Aβ(1-40)). Table 2 showed that all peptide binds with high affinity to heparin, as 
demonstrated by dissociation constants in the nanomolar range. However, d13, 14 
Aβ(1-40) shows a slightly lower binding constant compared to the other peptides. The 
double d-isomers d5, 6 Aβ(1-40) exhibits nearly identical thermodynamic binding 
parameters, suggesting that N-terminal domain is not important for GAG binding. 
Double-d substitutions in regions involved in the β-structure do not affect the binding 
constant of the Aβ(1-40)-heparin interaction, but lead to smaller binding 
stoichiometry and larger binding enthalpies. This indicates the importance of the 
basic cluster of H13-K16 for the GAG-binding and that binding is maximal when the 
residues assume a specific conformation 
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The salt dependence of the binding of Aβ(1-40) to heparin cannot be directly 
measured, but can be predicted using the oligolysine model for the salt-dependence of 
protein-polyelectrolyte interactions (27). At 100 mM NaCl, we predict a binding 
constant of , which is similar to reported binding constant of 
 for the melittin-heparin interaction under similar conditions (100 mM 
NaCl, net charge of the peptide +5) (29).  
The binding constant derived from the calorimetric data using the multisite binding 
model is the microscopic binding constant. For statistical reason, the binding constant 
for a specific binding step i to a macromolecule with n independent binding sites 
varies according to (40) 
  (7) 
Therefore, the binding constant for the first binding step correspond to , 
whereas the last peptide binds with . For the Aβ(1-40)-heparin interaction 
with a measured stoichiometry of , the  ratio is 289. . Thus, the first 
peptide has a 289 times higher binding constant as the last peptide. Such a high 
differences can be misinterpreted in terms two types of binding sites with high and 
low affinity, respectively (22). In vivo, the concentration of glycosaminoglycans can 
be assumed as in excess over Aβ(1-40), for which reason  
is applied, which corresponds to a dissociation constant of . 
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Physiological relevance of Aβ(1-40)-GAG interaction 
To our knowledge, this study is the first thermodynamic characterization of the 
interaction of monomeric Aβ(1-40) to glycosaminoglycans (GAGs). ITC experiments 
revealed a dissociation constant of  for the Aβ(1-40)-heparin interaction 
under the given experimental condition (low ionic strength, pH 3.7). Heparin 
naturally occurs in the granules of mast cells, and is therefore not directly available 
for Aβ(1-40) binding. However, heparin possesses a similar structure of the basic 
dissacharide unit compared to the physiologic more relevant heparan sulfate, but has 
a higher degree of sulfation (41). Earlier studies demonstrated that the dissociation 
constant of small cationic peptide to heparin was equal or only slightly lower (by one 
magnitude) compared to that of heparan sulfate, mainly due to the higher negative 
charge of heparin (22, 29). The involvement of GAGs in the Aβ fibrillization is based 
on findings that GAGs are colocalized in amyloid plaques (13) and that GAGs can 
accelerate the fibrillization process (14). Further, it was postulated that the Aβ-GAG 
interaction is a putative nucleation mechanism of the Aβ fibrillization in vivo (17). 
Indeed, CD experiments demonstrated that the presence of heparin at pH 3.7 induces 
a random-coil-to-β-structure transition in Aβ(1-40) (figure 4). However, no heparin-
induced conformational change in Aβ(1-40) was observed at pH 7.4 within 96 hr, as 
illustrated in figure 10. Even salt has a larger effect on the conformation of Aβ(1-40) 
than the presence of heparin. Therefore, we conclude that it is rather unlikely that an 
extracellular Aβ(1-40) binds to GAGs on the cellular membrane, representing a 
putative nucleation mechanism in vivo. This results are in line with previous study, 
reporting that monomeric Aβ(1-40) interacts with GAGs only in the pH range of 4 to 
6, whereas a fibrillar Aβ(1-40)-GAGs interaction was observed between pH 4 to 9 
12.1dK nM=
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(15). However, it was found that a small portion of Aβ is indeed bound to the 
membrane (42). A part of these membrane-bound Aβs could be bound to GAGs 
attached at the cell surface. Neuronal membranes have a negative surface potential, 
leading to a lower pH at the surface compared to the bulk pH, which facilitate a Aβ(1-
40)-GAG interaction. However, an alternative site of interaction emerges from the 
observation that Aβ(1-40) is formed not only at the plasma membrane, but also in the 
endosomes/lysosomes (42). The endosomal pH is , and therefore favoring the 
Aβ-GAG interaction. As the Aβ oligomerization was shown to start intracellularly 
(43), the interaction of Aβ to GAG could play a role in the nucleation process.  
  
5.5
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Figure Captions 
Figure 1. (A) Circular dichroism (CD) spectra of Aβ(1-40) dissolved in 5 mM 
sodium acetate with varying pH values from 3.7 to 4.2. From top to bottom at 198 
nm: pH 4.2, 4.1, 4.0, 3.9, 3.8 and 3.7. The spectra were recorded at peptide 
concentration of 18.3 µM at 25 °C. (B) Content of secondary structure versus the pH 
of the buffer solution: (■) β-structure and (●) random coil. 
 
Figure 2. Effect of NaCl on conformation of freshly dissolved Aβ(1-40).(A) Circular 
dichroism (CD) spectra of Aβ(1-40) dissolved in 5 mM sodium acetate (pH 3.7) 
containing various concentration of NaCl. Spectra from the bottom to the top at 
198nm: 0 mM, 5 mM, 10 mM, 15 mM, 20 mM and 100 mM NaCl. The spectra were 
recorded immediately dissolving the peptide and at a peptide concentration of 18.3 
µM at 25 °C. (B) Fraction of secondary structure of Aβ(1-40) are plotted against the 
NaCl concentration in 5 mM sodium acetate (pH 3.7): (■) β-structure and (●) random 
coil. 
 
Figure 3. CD spectra of Aβ(1-40) dissolved in sodium acetate (pH 3.7) of varying 
concentrations (5 mM to 25 mM). Spectra were recorded at a peptide concentration of 
18.5 µM at 25°C. 
 
Figure 4. Structural transition of Aβ(1-40) upon binding to heparin monitored by 
circular dichroism (CD) spectroscopy. All spectra were recorded in 5 mM sodium 
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acetate (pH 3.7) at 25 °C. Heparin-to-Aβ(1-40) ratio (r) varied between 0 and 0.25. 
(A) black, r=0; red, r=0.01; blue, r=0.02 and magenta, r=0.05. (B) black, r=0.06; red, 
r=0.07; blue, r=0.09; magenta, r=0.10 and olive, r=0.12. (C) black, r=0.15; red, 
r=0.17; blue, r=0.20; magenta, r=0.21; olive, r=0.22; navy, r=0.24 and violet, r=0.25. 
 
Figure 5. (A) Calorimetric trace obtained by titrating 28 µM heparin solution into a 
15.3 µM Aβ(1-40) solution (5 mM sodium acetate (pH 3.7)) at 25 °C. Each peak 
corresponds to an injection of 4 µl heparin solution, occurred at 5 min intervals. (B) 
Heats of reaction derived from the ITC experiment above are plotted against the 
molar ratio of heparin to Aβ(1-40). The solid line corresponds to the best fit of the 
multisite binding model to the experimentally determined  using the paramters: 
.  
 
Figure 6. Temperature dependence of the molar binding enthalpies of the binding of 
Aβ(1-40) to heparin . The molar binding enthalpies derived from ITC experiments are 
plotted against the measuring temperature. Each point corresponds to an ITC 
measurement. The solid line correspond to the regression line with a slope of  
.  
 
Figure 7. Temperature dependence of the binding constant of the Aβ(1-40)-heparin 
interaction. Dots correspond to experimentally measured binding constants (T=18, 25 
and 32 °C). Solid line corresponds to the calculated binding constant using vant’t 
ihδ
ihδ
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Hoff’s law and the temperature dependence of the molar reaction enthalpy as 
. 
Figure 8. Circular dichroism (CD) spectra of Aβ(1-40) and four double d-isomers (A) 
in aqueous solution and (B) in the presence of heparin. black: Aβ(1-40) , red: d5, 6, 
blue: d13, 14, magenta: d19, 20 and olive:d35, 36. The heparin-to-peptide molar ratio 
was about 2. Both heparin and Aβ(1-40) were dissolved in 5 mM sodium acetate (pH 
3.7) and the spectra were recorded at peptide concentration of 5.4-18 µM.  
Figure 9. Salt dependence of the binding constant  of the Aβ(1-40)-heparin 
interaction at pH 3.7. The solid lines were calculated by equation 6 using z-value of 
0.75 (black, experimentally predicted), 2.5 (red, half the nominal net charge) and 5 
(blue, nominal net charge).  
Figure 10. Aβ(1-40)-heparin interaction at pH 7.4 monitored by circular dichroism 
(CD) spectroscopy. The following buffers were used: (A-B) 5 mM Hepes (pH 7.4), 
(C-D) 5 mM Hepes (pH 7.4), 140 mM NaF. CD spectra were recorded at 0 (black), 
24 (red), 48 (blue) and 96 hr (olive) at peptide concentration of 15 µM (A, C) and 13 
µM (B, C). (A, C) Aβ(1-40) alone, (B, D) Aβ(1-40)-heparin (1:1, m:m).  
  
0 0 0
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Appendix 
In the previous section, we have studied the thermodynamics of the Aβ(1-40)-heparin 
interaction at pH 3.7 using isothermal titration calorimetry (ITC). At this pH, Aβ(1-
40) is monomeric, which is a prerequisite to determine the binding constant, and 
therefore the free energy of binding , from the calorimetric data. As previously 
discussed, Aβ(1-40)-GAG interaction is considered as highly pH dependent. 
Therefore, we were interested to study the effect of pH on the thermodynamics of the 
Aβ(1-40)-heparin interaction. However, circular dichroism (CD) spectroscopy 
revealed that Aβ(1-40) is not monomeric in the pH range of 3.8 to 7, which a priori 
precludes the determination of binding constants from calorimetric experiments. 
Nevertheless, we performed CD and ITC measurements in this pH range, namely at 
pH 4.7 and 6.0. Further, we studied the effect of salt (NaCl) on the thermodynamics 
of the Aβ(1-40)-heparin interaction at pH 5.0.  
Aβ(1-40)-heparin interaction at pH 4.7 
The interaction of Aβ(1-40) with heparin has been studied at pH 4.7 in 5 mM sodium 
acetate. First, CD spectroscopy was applied to examine effect of heparin on the 
conformation of Aβ(1-40). Figure 1A displays the CD spectra of Aβ(1-40) in buffer 
and mixed with different amounts of heparin. The heparin-to-Aβ(1-40) molar ratio (r) 
was increased from 0 to 0.18. The corresponding fractions of secondary structure 
were evaluated as described before, and are plotted versus in figure 1B. In buffer, 
Aβ(1-40) exhibits a major content of β-structure ( ) with minor content of 
random coil ( ), which demonstrates that Aβ(1-40) is not monomeric. The 
addition of heparin lead to an increase in β-structure of , whereas the content of 
random coil is decreased by the same magnitude.  
0G∆
r
70%
30%
15%
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ITC was used to study the thermodynamics of the binding reaction of Aβ(1-40) to 
heparin at pH 4.7. Figure 2A shows an ITC experiment, in which  aliquots of a 
 heparin solution were injected into the calorimetric cell containing a 
 Aβ(1-40) solution at 25 °C. Integration of the injection peaks yield in the 
heats of reaction . As illustrated in figure 2B,  is distinctly exothermic, but 
decreases with increasing injection number as less and less peptide is available for 
binding ( ). The injection of heparin into pure buffer yielded no significant heats 
of reaction  (data not shown). The calorimetric data cannot be analyzed using the 
multisite binding model, as Aβ(1-40) was not in its monomeric state as indicated by 
the high content of β-structure in the CD spectrum. Therefore, the only 
thermodynamic parameter, which can be derived from the calorimetric experiment, is 
the molar heat of reaction, , obtained by  
  (1) 
where is the total molar amount of Aβ(1-40) in the calorimetric cell. For the 
Aβ(1-40)-heparin interaction at pH 4.7, we measured a molar heat of reaction of 
 (5 experiments), which is distinctly higher compared to 
the molar binding enthalpy measured for the monomeric Aβ(1-40)-heparin interaction 
at pH 3.7 ( ).  
Aβ(1-40)-heparin interaction at pH 6.0 
At pH 6.0, Aβ(1-40)-heparin interaction was studied in 5mM sodium citrate, since 
sodium acetate can be only used in a pH range of 3.6 to 5.6. CD spectroscopy 
4 lµ
14.3 Mµ
21.7 Mµ
ihδ ihδ
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measurements showed that presence of heparin ( ) increased the content of β-
structure of Aβ(1-40) from 61% to 88% (figure 3). Figure 4A shows the calorimetric 
experiment, in which  aliquots of a  heparin solution were injected into 
the calorimetric cell containing a  Aβ(1-40) solution at 25 °C. The 
corresponding heats of reaction are displayed in figure 4B. The heparin-into-buffer 
titrations revealed no significant heats of dilution. The ITC experiment clearly 
demonstrated that Aβ(1-40) binds to heparin with a measurable molar heat of reaction 
of  (2 measurements). Interestingly, the binding enthalpy 
does not change much in the pH range of 4.7 to 6.0.  
Effect of NaCl on the Aβ(1-40)-heparin interaction at pH 5.0 
The effect of salt on the Aβ(1-40)-heparin interaction was studied by ITC in 5mM 
sodium acetate (pH 5.0) at 25°C. For this purpose, the concentration of NaCl was 
gradually increased in the buffer from 0 to 25 mM. For all concentrations of NaCl, 
ITC experiments were performed by titrating  aliquots of a  heparin 
solution into a  Aβ(1-40) solution (data not shown). The heparin-into-buffer 
control experiment revealed no significant heats. The molar heat of reaction  
was derived from the calorimetric data (as described above), and decreased with 
increasing salt concentration from  (0 mM NaCl) to  
(25 mM NaCl) as illustrated in figure 5. Linear regression analysis yields a linear 
dependence of  on the salt concentration with a correlation coefficient  
and a slope of . Using the regression equation, we 
can extrapolate the molar heat of reaction  to zero, obtaining a NaCl 
0.49r =
10 lµ 26.2 Mµ
15 Mµ
0 4.0 0.5 /AH kcal molβ∆ = − ±
10 lµ 40 Mµ
21.7 Mµ
0
AH β∆
4.3 /kcal mol− 0.5 /kcal mol−
0
AH β∆ 0.99r =
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concentration of . However, this does not prove that the Aβ(1-40)-heparin 
interaction is abolished at this salt concentration under the present experimental 
conditions.  
 
  
29.3mM
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 Appendix figure captions 
Appendix figure 1. Structural changes of Aβ(1-40) upon interaction with heparin 
measured by circular dichroism (CD) spectroscopy. All spectra were recorded in 5 
mM sodium acetate (pH 4.7) at 25 °C. (A) The heparin-to-Aβ(1-40) molar ratio (r) is 
varied from 0 (black), 0.11 (red), 0.13 (blue) and 0.18 (magenta).(B) Fraction of 
secondary structure plotted versus the corresponding heparin-to-Aβ(1-40) molar ratio: 
(■) β-structure and (●) random coil. The content of α-helix is below 0.5% for all 
spectra.  
 
Appendix figure 2. (A) Calorimetric trace obtained by injecting 4 µl aliquots of a 
14.3 µM heparin solution into a 21.7 µM Aβ(1-40) solution (5 mM sodium acetate 
(pH 4.7)) at 25 °C. (B) Heats of reaction  derived from the ITC experiment above 
are plotted against the injection number ni. 
 
Appendix figure 3. Conformational change of Aβ(1-40) upon binding to heparin as 
monitored by circular dichroism (CD) spectroscopy. All spectra were recorded in 5 
mM sodium citrate (pH 6.0) at 25 °C. The heparin-to-Aβ(1-40) molar ratio (r) is 0 
(black) and 0.49 (red).  
 
Appendix figure 4. (A) Raw data of an ITC experiment, in which 10 µl aliquots of a 
26.2 µM heparin solution into a 15 µM Aβ(1-40) solution (5 mM sodium citrate (pH 
ihδ
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6.0)) at 25 °C. (B) Heats of reaction  derived from the ITC experiment above are 
plotted against the injection number ni. 
 
Appendix figure 5. Effect of salt on the binding reaction of Aβ(1-40) to heparin. The 
molar heats of reaction, , are plotted versus the corresponding NaCl 
concentration in the buffer solution. is derived from the calorimetric data as 
discussed in the text. The solid line corresponds to the regression line with a slope of 
 and a intercept of .  
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4. Interaction of amyloid-β peptide with cationic lipid 
membranes 
Summary 
The amyloid-β peptide (Aβ) is the major component of amyloid plaques, which are a 
major pathological hallmark of the Alzheimer’s disease (AD). AD is major form of 
dementia with an estimated worldwide prevalence of 25 million. A growing body of 
evidences indicates that neuronal membranes play an important role in the disease. 
Particularly, the interaction of Aβ with lipid membranes is considered as a putative 
mechanism of the Aβ-mediated neurotoxicity.  
Here, we have studied the interaction of Aβ(1-40) to cationic small unilamellar 
vesicles (SUVs) using circular dichroism (CD) spectroscopy, isothermal titration 
calorimetry (ITC) and dynamic light scattering (DLS). CD spectroscopy reveals two 
sequential conformational transition of Aβ(1-40) upon binding to cationic lipid 
vesicles. A random-coil-to-β-structure transition was observed at low lipid-to-peptide 
molar ratios (L/P), followed by a transition to an α-helical structre at high L/P. The 
extent of membrane-induced β-structure of Aβ(1-40) was distinctly smaller for 
cationic lipid vesicles compared to anionic lipid vesicles (at pH 7.2). This is mostly 
explained by the large difference in the pH value at the membrane surface, which 
favors Aβ(1-40) aggregation more in the case of anionic lipid vesicles. ITC provides 
both the molar binding enthalpy ( ) and the binding isotherms, 
which were analyzed by a model combining a surface partition equilibrium with the 
Gouy-Chapman theory, revealing a surface partition constant of  and 
0 2.5 /H kcal mol∆ = −
1
0 0.11K M
−=
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an effective charge of   ( 20 mM Tris-HCl (pH 7.2)) at 25 °C. Further, DLS 
measurements demonstrates that the interaction of Aβ(1-40) with cationic lipid 
vesicles leads to vesicle aggregation.  
Manuscript: Interaction of amyloid-β peptide with cationic lipid 
membranes 
Introduction 
The amyloid-β peptide (Aβ) is one of the most studied peptide with more than 10’000 
related articles found in PubMed (National Library of Medicine). The high research 
activity on Aβ is primarily based on the amyloid-beta hypothesis, which states that 
the cerebral aggregation of Aβ is the putative cause of the Alzheimer’s disease (AD) 
(1, 2). AD is the major form of dementia, affecting 25 million people worldwide (3). 
In the future, the impact of AD will even increase with a predicted 106.8 million 
people affected in 2050 (4). AD is not only a personal tragedy for the patients and 
their families, but also a major challenge for the society. In particular, the financial 
costs of the disease are enormous with estimated worldwide costs of $422 billion in 
2009 (5).  
Several line of evidence suggests that the lipid membrane plays an eminent role in the 
pathology of AD. Thus, it has been shown that the degeneration of the brain cell 
membrane is accelerated in AD, as observed by the decrease in the content of 
phospholipids (6). Genetic, cell biology and epidemiology studies furthermore 
indicated that cholesterol is linked to AD. Cholesterol, a normal component of 
cellular membrane, is highly enriched in the brain (7). Controversial results were 
reported on the cholesterol content in the brain of AD patients. While some reported a 
2.8pz = −
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decrease in the cholesterol concentration (8), others have observed the opposite (9). 
However, cholesterol is considered to influence the production of Aβ. Aβ is formed 
by proteolytical cleavage of the amyloid precursor protein (APP) by two proteases 
called β- and γ-secretases (for review, (10)). In an alternative pathway, the non-
amyloidogenic pathway, the consecutive action of α- and γ-secretases generates a 
truncated Aβ peptide called p3, precluding the generation of Aβ. It is noteworthy to 
mention, that APP and the three secretases are transmembraneproteins. In vitro 
studies demonstrated that a depletion of cholesterol in neurons lead to inhibition of 
Aβ generation (11), most probably by an increased activity of α-secretase (12). 
Although not fully understood, the effect of cholesterol on the generation of Aβ can 
be ascribed to the cholesterol-induced changes in membrane properties, such as 
stiffness and fluidity (13).   
A variety of biophysical techniques, including circular dichroism (CD) spectroscopy, 
isothermal titration calorimetry (ITC), atomic force microscopy (AFM) and 
fluorescence spectroscopy, were applied to study the interaction of Aβ(1-40) with 
membranes. In general, liposomes composed of different lipids, including 
phospholipids, cholesterol or gangliosides, were used as membrane-mimicking 
systems. The binding of Aβ to lipid membranes is mainly driven by electrostatics and 
therefore dependent on the membrane charge, ionic strength and pH, which mainly 
effects the net charge of Aβ (see figure 1). Thus most studies reported no interaction 
when using neutral lipids such as phosphatidylcholine (PC) or sphingomyelin (SM) 
(14, 15). At physiological pH, Aβ binds only at low ionic strength to anionic lipid 
membranes (16), while no binding was observed at physiological salt concentrations 
(14, 17). The presence of anionic lipids induces two sequential structural transitions 
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of Aβ(1-40) dependent on the lipid-to-peptide molar ratio: a random-coil-to-β-
structure transition at low L/P ratios and a β-structure-to-α-helix transition at high L/P 
molar ratios (16). Further, Aβ has been demonstrated to disrupt the lipid membrane, 
compromising its barrier function (18) One explanation is the formation of pores or 
ion-channels which cause membrane depolarization and disruption of ionic 
homeostasis (19, 20). As an alternative mechanism, it was postulated that Aβ 
aggregates not fully permeate, but associate the membrane, causing membrane 
thinning and leakage (21).  
Here, we have studied the interaction of Aβ(1-40) with cationic small unilamellar 
vesicles (SUVs) composed of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) 
and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) in a molar ratio of 
1:3. The main difference between the two lipids concerns the head group, which lacks 
a phosphate group in case of DOTAP. In aqueous solution, DOTAP has the ability to 
forms bilayer structure alone and with other lipids (22). For example, 31P-NMR 
measurements of DOTAP/POPC mixtures (30/70 mol%) revealed a lamellar bilayer 
architecture (23). Cationic lipids such as DOTAP are widely used as transfection 
agents in gene delivery (24). In this respect, DOTAP is probably the most studied 
cationic lipid, primarily due to its free availability (never protected by patents) and its 
low cost. In general, cationic lipids do not occur in nature, with the exception of rare 
examples of phosphatidyllysine and phosphatidylarginine found in bacteria grown 
under special conditions (22). Therefore, the interaction of Aβ(1-40) to cationic lipids 
is not of physiological relevance. Nevertheless, the study of cationic lipid-Aβ(1-40) 
interaction might provide new insight for the Aβ(1-40)-lipid membrane interaction. In 
this study, CD spectroscopy experiments were performed to gain information of the 
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structural changes of Aβ(1-40) upon binding to cationic lipid vesicles. In addition, 
isothermal titration calorimetry (ITC) was used to study the thermodynamics of the 
binding reaction.  
 
Material and Methods 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-rac-glycerol (POPG), dissolved in chloroform, were purchased from Avanti 
Polar Lipids (Alabaster, AL). Aβ(1-40) was from rPeptide (Bogart, GA, USA). All 
other chemical were purchased from commercial sources at the highest purity and 
were used without further purification. 
Circular dichroism (CD) spectroscopy 
CD measurements were carried out with a Chirascan CD spectrometer (Applied 
Photophysics Ltd., Leatherhead, UK). Spectra were recorded between 190 and 250 
nm, with a step size of 1 nm, bandwidth of 1 nm and a time per point of 20 s. For all 
measurements, a quartz cuvette of 1 mm path length was used. The mean residue 
molar ellipticity, , was calculated for each data point according to 
  (1) 
where  is the observed ellipticity in millidegree,  is the peptide concentration in
,  is the optical path length in cm and the number of amino acids of the 
peptide. The mean molar residue molar ellipticity is given in . The 
[ ]θ
[ ] 510 obsMR c l n
θθ =
⋅ ⋅
obsθ c
Mµ l n
2 1degcm dmol−
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contents of secondary structure were calculated with a fitting program based on 
reference spectra determined by Reed and Reed (25) 
Dynamic light scattering (DLS) 
Size and ζ-potential measurements were performed on a Zetasizer Nano ZS 
instrument (ZEN3600; Malvern Instruments Ltd., Worcestershire, U.K) equipped 
with a HeNe laser  and a backscattering detection (scattering angle of ). 
Data were analyzed using the built-in software of the instrument.  
Preparation of lipid vesicles 
Small unilamellar vesicles (SUVs) composed of a binary lipid mixture were prepared 
as described as follows. A defined amount of lipid was filled into a 4-ml glass vial, 
with subsequent removal of chloroform with a soft stream of nitrogen and high 
vacuum overnight. The amount of lipid was weighed and a defined amount of second 
lipid was added in chloroform and the lipid mixture was dried as described before. 2 
ml buffer was added to the dried lipid film and the dispersion was extensively 
vortexed. The lipid dispersion was sonicated with a G11SP1 Special Ultrasonic 
Cleaner (Laboratory Supplies CO., Inc) for around 25 min. Metal debris from the 
titanium tip was removed by simple centrifugation at 14,000 rpm for 4 min using a 
Eppendorf 5415 C benchtop centrifuge (Vaudaux-Eppendorf AG, Schonenbuch, 
Switzerland).  
Isothermal titration calorimetry (ITC) 
Isothermal titration calorimetry (ITC) measurements were performed on a MicroCal 
VP ITC calorimeter (MicroCal, Northampton, MA). To avoid air bubbles, the 
solutions were degassed under stirring with a magnet bar for ~10 min (ThermoVac; 
(633 )nm 173°
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Microcal, Northampton, USA). For Aβ(1-40) solution, the buffer were degassed prior 
peptide dissolvement. Raw data were processed using the Origin software provided 
with the instrument.  
Preparation of Aβ(1-40) solution  
Aβ(1-40) samples were prepared as follows. First, the peptide was dissolved in 
hexafluoroisopropanol (HFIP) at a concentration of 0.5mg/ ml HFIP and equilibrated 
for one hour at room temperature. The treatment of Aβ(1-40) with HFIP dissolves 
pre-existing aggregates and define a chemical starting point. Next, a defined amount 
of Aβ(1-40)-HFIP solution was filled into a 4-ml glass vial. HFIP was removed first 
by soft stream of nitrogen and subsequently by high vacuum overnight. The samples 
were then stored at -20°C. Immediately prior to use, Aβ(1-40) was dissolved in the 
appropriate buffer at a peptide concentration below 30µM. The accurate peptide 
concentration was obtained by amino acid analysis (University of Bern).  
Binding model 
Binding isotherms, derived from calorimetric measurements, were analyzed with a 
surface partition model, in which the degree of peptide binding  is related to the 
peptide concentration immediately above the polar headgroup (26) 
  (2) 
where  is the surface partition constant. This model combines chemical partition 
equilibration with electrostatic interactions. Charged membrane, be it anionic or 
cationic, have a surface potential, , which attracts oppositely charged molecules in 
its vicinity. Thus, if peptide and membrane are oppositely charged, the peptide 
bX
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concentration is increased in the lipid-water interface compared to bulk solution and 
can be calculated using the Boltzmann equation: 
  (3) 
where  is the peptide concentration in the aqueous bulk solution,  the effective 
charge of the peptide (normally smaller than the nominal charge),  the Faraday 
constant, the universal gas constant and  the absolute temperature. By using the 
Gouy-Chapman theory, the surface potential, , can be connected with the surface 
charge density, , according to (27, 28): 
  (4) 
where  is the electric permittivity of free space,  the dielectric constant of water, 
 the concentration of the jth electrolyte in the bulk solution and  the signed 
valence of the jth electrolyte. The membrane surface charge, , can now be linked to 
the degree of binding, , by the following equation (29): 
  (5) 
where  is the elementary charge,  the surface area of lipid,  the molar 
fraction of DOTAP in the lipid membrane,  the mole fraction of bound chloride 
ions to the headgroups of DOTAP and  is the surface area of the inserting peptide 
(estimated as 50 Å). The term  considers that the surface charge is reduced by 
specific binding of chloride ions to the headgroup of DOTAP. In analogy to the Na+ 
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binding to POPG (30, 31), we assumed that Cl- binding to DOTAP follows a 
Langmuir isotherm with a binding constant of . Tris-HCl buffer was 
treated as 1-1 salt. By calculation of the surface potential  and the surface peptide 
concentration  for each data point of the binding isotherm, it is possible to 
determine the surface partition constant  and the effective peptide charge . The 
knowledge of the binding constant, , allows to calculate the free energy of binding, 
, according to  
  (6) 
where the factor  is the molar concentration of water. In turn, the entropy of 
binding, , can be calculated by the following equation 
  (7) 
where  is the molar binding enthalpy, directly derived from the calorimetric 
experiment.  
Calculation of the net charge of Aβ(1-40)  
The net charge of Aβ(1-40) at a particular pH corresponds to the sum of charges of all 
ionizable groups. The charge fraction of the ionizable groups were calculated using 
the Henderson-Hasselbach equation with the following pKa-values: C-terminus, 3.8; 
Asp, 4.3; Glu, 4.5; His, 6.5; N-terminus, 7.5; Tyr, 10; Arg, 12.5 (32).  
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Results 
Structure of Aβ(1-40) depending on pH, salt and concentration  
Circular dichroism (CD) spectroscopy were used to monitor the effect of pH on the 
secondary structure of freshly dissolved Aβ(1-40). Aβ(1-40) were dissolved in 5 mM 
phosphate buffer with pH values changing from 6.4 to 8.0 (in 0.2 steps). The 
corresponding CD spectra are displayed in figure 2. For better visualization, CD 
spectra were divided into a low pH and a high pH region. Figure 2A displays the CD 
spectra of Aβ(1-40) at pH 6.4 to 7.2. At pH 7.2, CD spectrum exhibits a minimum at 
198 nm which indicates a dominant content of random coil. With decreasing pH 
values, the ellipiticity at 198 nm is increased. An isosbestic point could be observed 
at 214 nm indicating a two-state random coil-to-β-structure transition. CD spectra 
were analyzed as described in the material and methods section, revealing the fraction 
of secondary structure. In figure 2C, the content of secondary structure were plotted 
versus the corresponding pH of the buffer solution. The increase in pH from 7.2 to 
6.4 leads to a decrease of the content of random coil by 23%, whereas the content of 
β-structure is increased by nearly the same magnitude. The content of α-helix remains 
nearly constant at 4%. Figure 2B summarized the CD spectra of Aβ(1-40) recorded in 
the pH range of 7.2 to 8.0. The obtained CD spectra were almost identical within this 
pH range, and correspond to mainly random coil (67%).   
CD spectroscopy were further employed to examine the effect of salt on the 
conformation of Aβ(1-40) immediately after dissolving in buffer solution (10 mM 
sodium phosphate (pH 7.0)) and after 24 hr equilibration. CD spectra were recorded 
at a peptide concentration of 15 µM at 25 °C. Figure 3A displays the CD spectra of 
freshly dissolved Aβ(1-40) with varying salt concentrations of 5 to 100 mM NaCl. 
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All spectra exhibit an ellipticity minimum at 198 nm, which indicates a major content 
of random coil structure. However, some spectra (especially the spectra with 100 mM 
NaCl) start to diverge, yielding in ellipticities at 198 nm in the range of 
. Figure 3B displays the CD spectra of the same 
Aβ(1-40) solutions after 24 hr equilibration. All spectra reveal the typical 
characteristics of a predominant random coil structure. In addition, the spectra are 
identical in the range of 250 nm to 200 nm regardless of the salt concentration.  
Analogous experiments were conducted at pH 8.0 (10 mM sodium phosphate), and 
the corresponding CD spectra are displayed in figure 4. As illustrated in figure 4A 
and 4B, the presence of salt induced similar effect on the freshly dissolved and 
equilibrated (24 hr) Aβ(1-40) at pH 8.0 compared to pH 7.0.  
Next, we investigated the effect of concentration on the conformation of Aβ(1-40) in 
5 mM sodium phosphate at the two pH 7.2 and 8.0. We gradually increased the 
peptide concentration of the CD samples from 19 to 153 uM. For both pH, the content 
of β-structure are plotted versus the corresponding peptide concentration, as displayed 
in figure 5. The increase in peptide concentration leads to an increase of β-structure, 
which is similar for both conditions.  
Structural changes of Aβ(1-40) upon binding to cationic lipid membrane 
We have employed CD spectroscopy to monitor structural changes of Aβ(1-40) upon 
binding to cationic lipid vesicles. CD spectra were recorded of Aβ(1-40) in buffer (10 
mM sodium phosphate buffer (pH 7.2)) and mixed with various amounts of small 
unilamellar vesicles (SUVs) composed of DOTAP/POPC (25/75 mol%). In this way, 
the lipid-to-peptide molar ratio (L/P) is increased from 0.0 up to 200. No isosbestic 
2 17380 12860degto cm dmol−− −
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point was observed for all spectra, indicating the involvement of more than two 
species in the equilibrium. For the sake of better visualization, CD spectra were 
divided depending on their lipid-to-peptide ratios in a low (figure 6A) and a high lipid 
region (figure 6B). CD spectra were analyzed as describe in material and methods, 
and the secondary structure content are plotted versus the lipid-to-peptide ratio as 
shown in figure 6C. The CD spectra of Aβ(1-40) in buffer exhibits a major content of 
random coil (63%) with minor content of β-structure (37%). In the low lipid region 
(L/P= 0 to 27), the addition of cationic lipid vesicles induces a random-coil-to-β-
structure transition with an isosbestic point observed at , as displayed in figure 
6A. The addition of cationic lipid vesicles leads to an increase in β-structure by 11%, 
while the content of random coil is decreased by the same extent. Further addition of 
cationic lipid vesicles (L/P=40 to 200) leads to an additional structural transition of 
the peptide from β-structure to α-helix with an observed isosbestic point at  
(figure 6B). The fraction of α-helix is gradually increased to 6% at a lipid-to-peptide 
ratio of 200.  
Analogous experiments were conducted at pH 8.0 (10mM sodium phosphate) in order 
to study the pH dependence of the conformational changes of Aβ(1-40) upon binding 
to cationic lipid vesicles. The obtained results were similar to these obtained at pH 7.2 
and are shown in figure 7. Here, the addition of cationic lipid vesicles leads to an 
increase in β-structure of 20%, which is higher compared to pH 7.2. Furthermore, the 
content of α-helix is increased higher (up to 18%), which can be ascribed to the fact 
that the measurements were recorded up to higher lipid-to-peptide molar ratios.  
210nm
202nm
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Structural changes of Aβ(1-40) upon binding to anionic lipid membrane 
To compare the conformational changes of Aβ(1-40) upon binding to cationic lipid 
membrane with those of anionic lipid membranes, similar CD experiments were 
performed with SUVs composed of POPC/POPG (25/75 mol%) at the two pH 7.2 
and 8.0 (10 mM sodium phosphate). Figure 8 displays the CD spectra of Aβ(1-40) in 
buffer and in presence of various amounts of anionic lipid vesicles at pH 7.2. An 
isosbestic point could be observed at 211 nm for all spectra, except for the spectrum 
with the highest lipid-to-peptide ratio (L/P=555). The addition of anionic lipid 
vesicles leads to a random-coil-to-β-structure transition with an increase in β-
structure of 42% as shown in figure 8B. The further addition of lipid vesicles leads to 
an additional structural transition of Aβ(1-40) to α-helix (figure 8A).  
A different picture was obtained when CD measurements were performed at pH 8.0. 
For better visualization, the CD spectra were separated into a low (figure 9A) and 
high lipid region (figure 9B). In the low lipid region (L/P=0 to 44), the addition of 
anionic lipid vesicles leads first to a shift in the minimum ellipticity from  to 
 and to a small increase from  to . In the high 
lipid region (L/P=44 to 533), the minimum is first shifted from  to  and 
increased from  to , followed by a shift from  to 
 and an decrease of  to . In figure 9C, the 
secondary structure content is plotted against the corresponding lipid-to-peptide ratio. 
As a general trend, the addition of anionic lipid vesicles lead to a decrease in random 
coil (from 65 to 26%), while the content of β-structure (from 33 to 60%) and α-helix 
(from 2 to 24%) is increased.  
200
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204 206nm
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Thermodynamics of the Aβ(1-40) binding reaction to cationic lipid vesicles 
Isothermal titration calorimetry (ITC) was used to characterize the thermodynamic 
properties of the Aβ(1-40) binding reaction to cationic lipid vesicles. By injecting the 
lipid vesicles into the peptide solution, the ITC experiment provide the binding 
isotherms, in which the binding ratio, , is expressed as a function of free peptide 
bulk solution, , according to, 
  (8) 
where  is the ratio of bound peptide,  , to the total molar amount of lipids,
. A detailed description how the binding isotherm is derived from the 
calorimetric data is given elsewhere (33). Figure 10A shows a typical calorimetric 
experiment, in which every 300 s 8 µl aliquots of a 20 mM lipid SUV suspension 
were titrated into a 15 µM Aβ(1-40) solution at 25 °C. Both Aβ(1-40) and lipids were 
dissolved in 20 mM Tris-HCl (pH 7.2). The calorimetric trace revealed an exothermic 
reaction for the injection of lipid vesicles into the Aβ(1-40) solution. The heats of 
reaction  were obtained by integration of the injections peaks and were plotted 
versus the injection number in figure 10B.  were initially exothermic and decreased 
with increasing injection number as less and less peptide was available for binding. 
At the end of the titration,  is nearly constant revealing the heat of dilution of 
. As a control experiment, a lipid-into-buffer experiment was conducted, 
revealing no significant heats of reaction (figure 10C). The molar binding enthalpy, 
, can be derived directly from the calorimetric experiment and is calculated 
according to 
bX
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  (9) 
where  is the molar amount of peptide in the calorimetric cell ( ). 
For 20 mM Tris-HCl (pH 7.2), a molar enthalpy of  was 
measured for the Aβ(1-40) binding reaction to cationic lipid vesicles. The binding 
isotherm (figure 10D) was analyzed using the surface partition model described in the 
material and methods section. The solid line in figure 10D corresponds to the best fit 
using a  and . Moreover, additional important 
thermodynamic binding parameters can be determined, such as the free energy of 
binding of  and the entropy of binding of 
. Peptide binding is therefore driven by the enthalpy  and opposed by 
entropy .  
Analogous ITC experiments were conducted for two additional buffers (Hepes and 
Mops) at pH 7.2. For Mops buffer (20 mM), figure 11A shows the ITC experiment 
obtained by injecting cationic lipid vesicles into a Aβ(1-40) solution at 25 °C. The 
injection of lipid vesicles caused an endothermic reaction as shown by the 
calorimetric trace. Heat of reactions  were decreased with increasing injection 
number and reached a constant heats of dilution of . As a control 
experiment, a lipid-into-buffer control experiment was conducted and is shown in 
figure 11B. With the exception of the first injection ( ), the heats of reaction 
were endothermic, with decreasing values from  with increasing injection 
number. An overlay of the heats of reaction  obtained from the lipid titrations into 
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buffer and Aβ(1-40) solution (figure 11C) illustrates that the decrease in  is so 
similar that it cannot be clearly distinct between the two types of experiments. 
Therefore, it is not appropriate to derive neiter the molar binding enthalpy, , nor 
the binding isotherm from the calorimetric data.  
In the case of Hepes buffer (20 mM), the lipid-into-peptide titration experiment at 25 
°C is shown in figure 12A. Here, the heats of reaction  were at first endothermic, 
became exothermic and then gradually changed to endothermic again with heats of 
dilution of  (figure 12B). The lipid-into-buffer injections revealed 
constant heats of reaction of  (figure12C). Because these  are 
considerably higher than the obtained heats of dilution, it is not appropriate to 
calculate the molar binding enthalpy. In addition, the binding isotherm could not be 
fitted using the surface partition model described above. Therefore, any 
thermodynamic binding parameter could be derived from the calorimetric data in 
Hepes buffer.  
DLS measurements with cationic lipid membrane  
Dynamic light scattering (DLS) is straightforward method to determine the size and 
ζ-potential of colloid particles, such as lipid vesicles. The determined ζ-potential 
corresponds to the electric potential at the plane of shear. However, the ζ-potential 
can be used to calculate the surface potential if the location of the plane of shear is 
either known or assumed (34). Here, dynamic light scattering (DLS) were used to 
obtain information about the effect of Aβ(1-40) on the size and ζ-potential of cationic 
SUVs composed of DOTAP/POPC (25:75 mol%). All DLS samples contain 
cationic lipid vesicles, which were mixed with various amounts of Aβ(1-40). In this 
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way, the peptide concentrations were gradually increased from , yielding 
peptide-to-lipid ratios in the range of 0 to 1.49. In Figure 13, both the size and the ζ-
potential of cationic lipid vesicles were plotted versus their corresponding 
concentration of Aβ(1-40). In absence of Aβ(1-40), the lipid vesicles have a size of 
 and a ζ-potential of . As illustrated in figure 13A, even low 
concentrations of Aβ(1-40) ( ) lead to 2-fold increase in the particle size from 
. Interestingly, a moderate increase in the particles size from 
 could be observed in the added peptide concentration range of 1.3 to 6 
µM. At higher peptide concentration, the size of the particles sharply increase to a 
size of . Figure 13B shows the effect of Aβ(1-40) on the ζ-potential of the 
cationic lipid vesicles. An increase in the peptide concentration leads to a decrease in 
the ζ-potential from 29 mV to 14 mV. However, electrical neutrality has not been 
observed in the studied peptide range.  
Discussion 
Structure of Aβ(1-40) influenced by salt, pH and concentration 
CD spectroscopy measurements demonstrate that the Aβ(1-40) fibrillization is 
favored with decreasing pH from 7.2 to 6.4, as indicated by the increase of β-structure 
content of the freshly dissolved peptide. On the other hand, the CD spectra of freshly 
dissolved Aβ(1-40) are constant in the pH range of 7.2 to 8.0, which suggests a minor 
effect of pH on the fibrillization process in this pH range. These results are in line 
with previous reports on an Aβ aggregation maximum between pH 4 to 7 (35, 36). 
For reason of exactness it is noteworthy to mention, that the ionic strength of a buffer 
solution of constant concentration varies with varying pH values. However, in case of 
0 14.8to Mµ
58nm 29mV
1.3 Mµ
58 124to nm
124 162to nm
1 mµ>
Chapter 4 
 - 132 -  
10 mM sodium phosphate, the ionic strength is decreased from 0.028 M at pH 7.2 to 
0.013 M at pH 6.4, and can therefore be omitted as an explanation for the pH induced 
structural transition. Further, the presence of salt induces no conformational change in 
Aβ(1-40) within 24 hrs as showed in figure 3 and 4 at pH 7.0 and 8.0, respectively. 
However, small changes in the CD spectrum was observed for freshly dissolved 
peptide at high salt concentrations (especially 100 mM) compared to the 
corresponding spectra recorded under low ionic strength conditions. This effect, 
which disappeared after 24 hr of equilibration, is not a change in conformation, but 
can be best explained by a salt-induced decrease in the peptide solubility. As outlined 
in the material and methods section, CD spectra were initially recorded in mdeg, but 
converted to mean residue molar ellipticity, , in . The conversion 
equation requires the knowledge of the peptide concentration. By using a lower 
peptide concentration than the nominal concentration , CD spectra recorded 
at high ionic strength conditions perfectly overlay with those at low ionic strength. At 
100 mM NaCl, the difference between the actual and nominal peptide 
concentration is . This is a serious source of error, as the Aβ(1-40) 
concentration cannot be determined directly (e.g by UV absorbance at 280 nm). In 
general, salt affects the peptide solubility in addition with other factors, such as the 
peptide length, amino acid composition, pH and temperature (37).  
Further, CD spectroscopy have demonstrated that the increase of peptide 
concentration cause an increase in β-structure, which was similar at pH 7.0 to 8.0. 
This was previously demonstrated for slightly different conditions (5 mM Mops, pH 
7.4) (14). Differences with respect to concentration-induced β-structure might be 
[ ]θ 2 1degcm dmol−
(15 )Mµ
( 5.8 )Mµ
300%
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ascribed due to differences in buffer, sample preparation and chemical history of the 
peptide.   
Structural changes of Aβ(1-40) upon binding to cationic lipid vesicles 
CD spectroscopy demonstrates that the interaction of Aβ(1-40) to cationic lipid 
vesicles induces first a transition from random-coil to β-structure, followed by a 
transition to α-helix at high lipid-to-peptide molar ratios. The interaction of Aβ(1-40) 
to negatively charged lipid membranes has been previously studied at pH 7.4, 
revealing first a lipid-induced random-coil to β-structure, followed by a transition to 
α-helix at high lipid-content (16). These experiments were repeated for phosphate 
buffer at pH 7.2 and 8.0, in order to avoid differences due to different buffer, peptide 
sample preparation and pH. At pH 7.2, CD measurements revealed lipid-induced 
structural transition of Aβ(1-40) as previously reported (16). However, large 
differences were observed for measurements at pH 8.0 (figure 9). Here, we observed 
a simultaneously increase of β-structure and α-helix, while the content of random coil 
is decreased. Why these results at pH 8.0 were so different to those obtained at pH 7.2 
and 7.4, is not understood.  
However, our focus lies on the lipid-induced increase in β-structure of Aβ(1-40). The 
results obtained for the 4 conditions (charged lipid (DOTAP vs. POPG), pH (7.2 vs. 
8.0) are summarized in figure 14. The highest increase in β-structure was observed 
for anionic lipid vesicles at pH 7.2. The membrane-induced increase in β-structure of 
Aβ(1-40) has its molecular origin in the combined effects of electrostatic attraction, 
the increase in peptide concentration at the membrane surface and aggregation (38). 
Lipid vesicles containing either positively or negatively charged lipids have a surface 
membrane potential , which attracts oppositely charged residues of Aβ(1-40) to the ψ
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membrane surface, leading to an increase in peptide concentration at the membrane 
surface. The peptide concentration at the membrane surface, , can be calculated 
using the Boltzmann equation (see equation 3) with the knowledge of the membrane 
surface potential, , and the charge of the peptide, . By using equation 4 and 5, 
the surface potential can be estimated at low ionic strength as  for the two 
lipid systems. Calculations of the net charge revealed that Aβ(1-40) is negative at pH 
7.2  and pH 8.0 as displayed in figure 1. Therefore, it seems even 
surprising that Aβ(1-40) can bind to anionic lipid membranes at the two pH. 
However, it can be postulated that the net charge is not solely decisive, but that the 
electrostatic interactions are mediated by a basic cluster of amino acids (His13-His14-
Lys16) of Aβ(1-40). Further, the pH at the surface of charged lipid vesicles is changed 
compared to the bulk value (by 2.5 Unit for ), due to the attraction of 
protons or hydroxyl ions in its vicinity. For anionic lipid vesicles at a bulk pH of 7.2, 
the surface pH is therefore lowered to 4.7 and leads to a positive net charge of Aβ(1-
40) in the membrane vicinity. However, the surface pH of cationic lipid vesicles is 
increased to a value of 9.7, which leads to an even more negative net charge of Aβ(1-
40). We can therefore conclude that the electrostatic attraction and, in turn, the 
peptide concentration at the membrane surface, is at least equal, if not higher in case 
of cationic lipid vesicles. However, the increased peptide concentration at the 
membrane surface leads to peptide aggregation, as indicated by the spectral change to 
β-structure. The aggregation of Aβ(1-40) is dependent on several factors, such as 
peptide concentration (14), pH (35, 36), temperature (39) and salt (40). With regard to 
pH, an aggregation maximum was reported in the pH range of 4 to 7 (35, 36). As 
discussed above, anionic lipid vesicles have under the given experimental conditions 
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a surface pH of 4.7, which is in the reported aggregation maximum. This explains the 
higher membrane-induced β-structure for anionic lipid vesicles in comparison to 
cationic lipid vesicles.  
Thermodynamic of the lipid-peptide interaction 
Isothermal titration calorimetry (ITC) is a useful tool to study thermodynamics of 
peptide-lipid interactions, such as the binding of Aβ(1-40) to cationic lipid vesicles. 
Calorimetric measurements conducted in Tris-HCl buffer directly revealed the molar 
bindings enthalpy of  and the bindings isotherm, which was 
analyzed with a surface partition model, yielding a surface partition constant of 
 and an effective peptide charge of . Analogous calorimetric 
experiments were previously conducted for anionic lipid vesicles at 28 °C, revealing a 
molar binding enthalpy of (10 mM Tris-HCl (pH 7.4)), a 
surface partition constant of  and an effective peptide charge of  
(the latter two parameters determined for Mops (pH 7.4)) (14). Although the 
thermodynamic binding parameters are often temperature-dependent, the slight 
temperature difference (25 to 28 °C) between the two data sources can be neglected. 
The large difference between the molar binding enthalpies can be mainly explained 
by the lower membrane-induced increase in β-structure of Aβ(1-40) upon binding to 
cationic lipid vesicles. Studies with double d-isomers of Aβ(1-40) revealed the 
thermodynamics of the β-structure formation of Aβ(1-40). Membrane-induced β-
structure formation has an enthalpy of , which 
constitutes the major contribution to the molar binding enthalpy (chapter 2). 
However, the two surface partition constants are in a similar range, which can be 
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expected, as  denotes for the transfer of the peptide from the plane of binding 
(peptide concentration ) into the lipid bilayer surface. Moreover, the two peptide 
charges are in the expected range.  
The binding of Aβ(1-40) to cationic lipid membrane is likely to be associated with the 
release or absorption of protons, as it was previously observed for the binding to 
anionic membranes (14). Protonation (or deprotonation) reactions can be directly 
measured with isothermal titration calorimetry by studying the binding reactions in 
buffers with different dissociation enthalpies (41). In addition to Tris-HCl 
, the binding of Aβ(1-40) to cationic lipid vesicles were 
also studied in Mops and in Hepes 
(42). As illustrated in corresponding figures 10, 11 and 12, 
the use of different buffers had a tremendous effect on the calorimetric experiments. 
Unfortunately, the use of Mops and Hepes also affected the lipid-into-buffer 
titrations, which were designed as a control experiment. For this type of experiments, 
the heats of reaction are normally in the range of  (as for Tris-HCl). 
However, for both Hepes and Mops, heats of reaction of  were measured. A 
possible explanation for these unusual findings comes from specific interactions of 
buffer molecules to the headgroup of DOTAP. Since the molar binding enthalpy 
could not be derived from the calorimetric measurements in Hepes and Mops, the 
uptake/release of protons associated with the Aβ(1-40) binding reaction to cationic 
membrane could not be determined.   
Furthermore, dynamic light scattering (DLS) was applied to study the effect of Aβ(1-
40) on the size and the ζ-potential of cationic lipid vesicles. As illustrated in figure 
0K
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14, DLS measurements demonstrates that the binding of Aβ(1-40) to cationic lipid 
vesicles leads to vesicle aggregation, as previously observed for anionic lipid vesicles 
(43). 
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Captions to figures 
Figure 1. The net charge of Aβ(1-40) dependent on the pH of the buffer solution. As 
described in the material and method section, net charge was calculated using the 
Henderson-Hasselbach equation with the corresponding pKa-values.   
 
Figure 2. Effect of pH on the conformation of the freshly dissolved Aβ(1-40). (A) 
Circular dichroism (CD) spectra of Aβ(1-40) dissolved in 5 mM phosphate buffer 
with varying pH values from 6.4 to 7.2 (in 0.2 steps). From bottom to the top at 198 
nm: pH 7.2, 7.0, 6.8, 6.6 and 6.4. The spectra were recorded at a peptide 
concentration of 15 µM at 25 °C. (B) CD spectra of freshly dissolved Aβ(1-40) with 
varying pH values from 7.2 to 8.0. (C) Content of secondary structure versus the pH 
of the buffer solution: (■) β-structure, (●) random coil and (▲) α-helix.  
 
Figure 3. Effect of NaCl on the conformation of freshly dissolved and 24 hr 
equilibrated Aβ(1-40) at pH 7.0. (A) CD spectra of Aβ(1-40) freshly dissolved in 10 
mM sodium phosphate buffer containing various concentration of NaCl. Spectra from 
bottom to the top at 198 nm: 0 mM, 15 mM, 5 mM, 25 mM, 10 mM, 20 mM and 100 
mM NaCl. The spectra were recorded immediately after dissolving the peptide and at 
a peptide concentration of 15 µM at 25 °C. (B) CD spectra of the corresponding 
Aβ(1-40) solutions (see (A)) equilibrated for 24 hr.  
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Figure 4. (A) CD spectra of Aβ(1-40) freshly dissolved in 10 mM sodium phosphate 
buffer (pH 8.0) containing various concentration of NaCl. Spectra from bottom to the 
top at 198 nm: 0 mM, 10 mM, 5 mM, 20 mM, 25 mM and 100 mM NaCl. The 
spectra were recorded immediately after dissolving the peptide and at a peptide 
concentration of 15 µM at 25 °C. (B) CD spectra of the corresponding Aβ(1-40) 
solutions (see (A)) equilibrated for 24 hr.  
 
Figure 5. Concentration-induced conformational change of Aβ(1-40) monitored by 
CD spectroscopy at pH 7.2 (●)  and 8.0 (■) in 5 mM sodium phosphate . Spectra were 
recorded at varying peptide concentrations of 19 to 153 uM at 25 °C.  
 
Figure 6. Conformational change of Aβ(1-40) upon binding to SUVs composed of 
DOTAP/POPC (25/75 mol%) monitored by CD spectroscopy. Spectra were recorded 
in 10 mM sodium phosphate (pH 7.2) at 25 °C. Lipid-to-peptide molar ratios of the 
spectra varied between 0 and 200. (A) black, L/P=0; magenta, L/P=7; blue, L/P=13 
and red, L/P=27. (B) black, L/P=40; red, L/P=53; blue, L/P=67; magenta, L/P=100 
and olive, L/P=200. (C) Fraction of secondary structure was plotted vs. the 
corresponding lipid-to-peptide ratio: (■) β-structure, (●) random coil and (▲) α-helix.  
 
Figure 7. Structural transition of Aβ(1-40) upon binding to positively charge SUVs 
DOTAP/POPC (25/75 mol%) as measured by CD spectroscopy. All Spectra were 
recorded in 10 mM sodium phosphate (pH 8.0) at 25 °C. Lipid-to-peptide molar ratios 
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of the spectra varied between 0 and 348. (A) black, L/P=0; red, L/P=6 and blue, 
L/P=14. (B) black, L/P=29; red, L/P=44; blue, L/P=116; magenta, L/P=174 and olive, 
L/P=348. (C) Fraction of secondary structure was plotted vs. the corresponding lipid-
to-peptide ratio: (■) β-structure, (●) random coil and (▲) α-helix.  
 
Figure 8. Conformational change of Aβ(1-40) upon binding to negatively charged 
SUVs composed of POPG/POPC (25/75 mol%) as measured by CD spectroscopy. 
Spectra were recorded in 10 mM sodium phosphate (pH 7.2) at 25 °C. Lipid-to-
peptide molar ratios varied between 0 and 533. (A) black, L/P=0; red, L/P=22; blue, 
L/P=44; navy, L/P=89; magenta, L/P=178; olive, L/P=266 and violet, L/P=533. (B) 
Plot of fraction of secondary structure vs. the corresponding lipid-to-peptide ratio: (■) 
β-structure, (●) random coil and (▲) α-helix.  
 
Figure 9. Structural change of Aβ(1-40) upon binding to anionic SUVs composed of 
POPC/POPC (25/75 mol%) as measured by CD spectroscopy at pH 8.0. Spectra were 
recorded in 10 mM sodium phosphate at 25 °C. Lipid-to-peptide molar ratios of the 
spectra are in the range of 0 to 533. (A) black, L/P=0; red, L/P=9 ; blue, L/P=13 and 
magenta, L/P=44. (B) magenta, L/P=44; black, L/P=89; red, L/P=178; blue, 
L/P=267and olive, L/P=533. (C) Fraction of secondary structure was plotted versus 
the corresponding lipid-to-peptide molar ratio: (■) β-structure, (●) random coil and 
(▲) α-helix.  
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Figure 10. The binding of Aβ(1-40) to cationic SUVs in 20mM Tris-HCl (pH 7.2) as 
observed by isothermal titration calorimetry. (A) Experimental heat flow as obtained 
by the injection of cationic SUVs (DOTAP/POPC (25/75 mol%)) into a 15 µM Aβ(1-
40) solution at 25 °C. (B) Heats of reaction  were plotted vs. the injection number 
. (C) Heat flow obtained by the injection of cationic SUVs into pure buffer at 25 
°C. (D) Binding isotherm derived from the calorimetric experiment displayed in (A). 
The solid line corresponds to the best fit of the surface partition model with a 
 and . 
 
Figure 11. ITC experiment of the Aβ(1-40) binding reaction to cationic SUVs in 20 
mM Mops (pH 7.2). (A) Calorimetric trace obtained by the injection of cationic 
SUVs (DOTAP/POPC (25/75 mol%)) into a 15 µM Aβ(1-40) solution at 25 °C. (B) 
Heat flow obtained by the injection of cationic SUVs into pure buffer at 25 °C. (C) 
Heats of reaction  of (A) and (B) were plotted vs. the injection number . 
 
Figure 12. ITC experiment of the Aβ(1-40) binding to cationic SUVs in 20 mM 
Hepes (pH 7.2). (A) Experimental heat flow obtained by the injection of cationic 
SUVs (DOTAP/POPC (25/75 mol%)) into a 15 µM Aβ(1-40) solution at 25 °C. (B) 
Heat flow obtained by the injection of cationic SUVs into pure buffer at 25 °C. (C) 
Heats of reaction  were plotted vs. the injection number . 
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Figure 13. Effect of Aβ(1-40) on the size and ζ-potential of SUVs composed of 
DOTAP/POPC (25/75 mol%) measured by dynamic light scattering (DLS). The total 
lipid concentration was 20 µM, and the peptide concentration was increased from 0 to 
14.8 µM. Both Aβ(1-40) and the lipid vesicles were dissolved in 10 mM phosphate 
(pH 7.2). All measurements were conducted at 25 °C. (A) Vesicle size was plotted vs. 
the concentration of Aβ(1-40). (B) ζ-potential of vesicles dependent on the peptide 
concentration.  
 
Figure 14. Dependence of the membrane-induced β-structure formation of Aβ(1-40) 
on the charge of lipid vesicles and pH of buffer solution. Data were taken from figure 
7, 8, 9 and 10. The corresponding fraction of β-structure was plotted vs. the lipid-to-
peptide ratios: (■) DOTAP, pH 7.2, (●) DOTAP, pH 8.0, (▲) POPG, pH 7.2 and (▼) 
POPG, pH 8.0 
 
  
Chapter 4 
 - 146 -  
 
Figure 1 
 
 
 
  
Chapter 4  
- 147 - 
 
Figure 2 
 
  
Chapter 4 
 - 148 -  
 
Figure 3 
  
Chapter 4  
- 149 - 
 
Figure 4 
  
Chapter 4 
 - 150 -  
 
Figure 5 
 
  
Chapter 4  
- 151 - 
 
Figure 6 
  
Chapter 4 
 - 152 -  
 
Figure 7 
  
Chapter 4  
- 153 - 
 
Figure 8 
  
Chapter 4 
 - 154 -  
 
Figure 9 
  
Chapter 4  
- 155 - 
 
Figure 10 
  
Chapter 4 
 - 156 -  
 
Figure 11 
  
Chapter 4  
- 157 - 
 
Figure 12 
  
Chapter 4 
 - 158 -  
 
Figure 13 
  
Chapter 4  
- 159 - 
 
Figure 14 
 
 
 
 
 

Summary  
- 161 - 
5. Summary 
The aim of the thesis is a better understanding of the thermodynamics and structural 
aspects of the interaction of Aβ(1-40) with lipid membranes and glycosaminoglycans 
(GAGs). We investigate the thermodynamic driving forces of the random-coil-to-β-
structure transition of Aβ(1-40) in a membrane environment. In contrast to previous 
reports, we use anionic lipid vesicles coated with the polymer poly(ethylenglycol) 
(PEG), which prevents vesicle aggregation. Circular dichroism (CD) spectroscopy 
demonstrate that PEGylated vesicles induce a random-coil-to-β-structure transition 
with a defined conformational endpoint in Aβ(1-40) and four double d-isomers. The 
additional transition to α-helix of Aβ(1-40), reported in earlier studies for high lipid-
to-peptide molar ratios of non-PEGylated anionic vesicles, was diminished. Hence, 
the defined conformational endpoint allows for the quantification of the membrane-
induced β-structure, which is dependent on the location of the double-d substitution in 
the peptide sequence. Isothermal titration calorimetry (ITC) reveals the 
thermodynamic binding parameters for the studied peptides. The thermodynamic 
parameters of the β-structure formation are deduced by correlating the structural data 
with the thermodynamic binding parameters. In addition, we study the effect of pH on 
the thermodynamic binding parameters of Aβ(1-40). 
In order to elucidate the role of GAGs in the Aβ(1-40) fibrillization process, we 
investigate the interaction of Aβ(1-40) with heparin. First, CD measurements 
demonstrate the effect of physico-chemical parameters, including pH, ionic strength 
and temperature, on the conformational state of Aβ(1-40). These measurements lead 
to experimental conditions, in which the interaction of monomeric Aβ(1-40) with 
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heparin can be studied. The monomeric state of Aβ(1-40) is a prerequisite for a full 
thermodynamic characterization of the interaction by ITC. Under the given 
conditions, ITC experiments demonstrate that Aβ(1-40) interacts with high affinity 
with heparin. CD spectroscopy reveals a structural transition of Aβ(1-40) from 
random-coil to β-structure. By studying the double-d isomers of Aβ(1-40), we 
identify a molecular pattern of the Aβ(1-40)-heparin interaction. We predict the 
binding constant for the Aβ(1-40)-heparin interaction at physiological ionic strength 
by using the oligolysine model. Finally, CD measurements reveal that GAGs do not 
induce a structural transition of Aβ(1-40) at physiological pH. 
In the last part of the thesis, the interaction of Aβ(1-40) to cationic lipid vesicles is 
studied. CD spectroscopy measurements demonstrat that Aβ(1-40) undergoes two 
sequential structural transitions upon the binding to cationic membranes. First, a 
random-coil to β-structure transition is observed, followed by a transition to an α-
helix at high lipid-to-peptide molar ratios. Compared to anionic lipid vesicles, the 
membrane-induced β-structure of Aβ(1-40) is less pronounced for cationic 
membranes, mainly due to the higher pH value at the membrane surface. The 
thermodynamics of the Aβ(1-40) membrane binding is studied with ITC for three 
buffer conditions, namely Tris-HCl, Mops and Hepes. Dynamic light scattering 
measurements show that the binding of Aβ(1-40) induces the formation of large 
aggregates.  
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